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DEFINITION OF VARIABLES 
The following variables were measured and evaluated for this research. The definition for each 
variable is provided; differences between chapter two and three on the variable are noted. 
 
Demographic Characteristics 
The following variables were measured by self-report through survey questionnaires. 
Age and Gender: Participants self-reported age in years and gender as male or female. 
Race/Ethnicity: Race was classified as Mexican American, Other Hispanic, Non-Hispanic 
white, Non-Hispanic black, Non-Hispanic Asian, or other non-Hispanic/Multirace based on the 
National Health and Nutrition Examination (NHANES) categories1 for chapter two. For chapter 
three, race was classified as American Indian, Asian, Hawaiian, Black, White, or Multi-Race.  
Education: Participants were asked to mark their highest level of educational attainment based 
on grade levels and college education. Education level was dichotomized to below high school, 
or high school and above.  
Marital Status: Participants self-reported being married, living with a partner, divorced, 
widowed, separated, or never married (single).  Marital status was dichotomized to 
married/cohabitating, or not (widowed, divorced, separated, or never married/single).  
Income Status: Participants were asked to report their annual household/family income either by 
$5,000 increments or $10,000 increments from zero dollars to $100,000 or above. For chapter 
two, this information was viewed as an income to poverty ratio based on The Department of 
Health and Human Services (HHS) poverty guidelines2. These are yearly defined guidelines used 
to determine eligibility for federal supplemental programs such as SNAP.  A ratio of ≤ 1 is 
considered below the poverty line, and >1 is above the poverty line. For chapter three it was 
viewed in dollar amount.  
vii 
 
Health History Characteristics 
The following variables were measured by self-report through survey questionnaires to assess the 
presence of risk factors for chemosensory issues. Noted is if each variable is used in both, or one 
study.  
Self-rated health status: Participants were asked to self-rate their overall general health as 
excellent, very good, good, fair, or poor as part of the NHANES questionnaires3. Health status 
was dichotomized to excellent/very good/good vs. fair/poor. This variable was not assessed in 
chapter three.  
Sinonasal problems: Participants were asked if they experienced either frequent nasal 
congestion, or a cold/flu that lasted longer than a month during the past year. The variable was 
dichotomized to presence/absence of these sinonasal issues in both studies.  
Xerostomia: Participants were asked if they experience persistent dry mouth or not enough 
saliva during the past year (yes/no). This variable was used in both studies.  
Serious head or face injury: Participants were asked if they ever experienced a broken nose or 
serious face injury, or lost consciousness due to a head injury. This was dichotomized to yes/no 
in both studies. 
Tonsillectomy: Participants were asked if they ever had their tonsils removed, either as an adult 
or as a child (yes/no). This variable was used in both chapter two and three. 
Frequent Ear infections: Participants were asked if they have ever had three or more ear 
infections (yes/no). They were asked to think back to when they were a child and include these 
instances as well. This variable was not used in chapter three.  
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Alcohol consumption: Participants were asked about their alcohol consumption as part of the 
examination section of NHANES4. A heavy drinker was classified as reporting having 4/5 drinks 
on almost every day, either formerly or currently. This variable was not used in chapter three. 
Body Mass Index (BMI): Body Mass index was calculated based on participant’s self reported 
height and weight. The equation is:  
 
BMI was classified with the CDC definitions for underweight, normal weight, overweight, obese 
grade I, obese grade II, and obese grade III5.   
 
Cigarette Use 
The following variables were measured by self-report and/or objective measure to assess current 
and former cigarette smoking use.  
Cigarette Smoker: In chapter two, participants were classified as never, current, or former 
cigarette smokers based on self-reported use. A smoker was classified as ever smoking 100 
cigarettes in their lifetime.  In chapter three, an inclusion criterion for the study was smoking at 
least ten cigarettes a day. Participants in both studies were asked to self-report average cigarettes 
smoked per day as well as number of years they currently or previously smoked. Smokers were 
further classified in chapter two based on the following measurements, which are described in 
more detail in the methods section of chapter two: 
 Pack Years: Determined based on packs smoked/day * years smoked. 
Time to first cigarette (TTFC): Based on self-reported time to first cigarette upon waking 
in the morning. This is classified as within 30 minutes of waking, or after 30 minutes of 
waking.  
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Serum Cotinine Level: Blood serum cotinine level was measured through a blood draw. 
Cotinine is a metabolite of nicotine used to measure recent cigarette use or exposure. A 
value of less than 10 ng/mL or ≥ 10 ng/mL was used.  
Menthol Status: In chapter three, smokers were further classified by menthol status. Responses 
to brand of cigarette used classified participants as menthol or non-menthol smokers. 
Preferred Electronic Cigarette Flavor: In chapter three, cigarette smokers trialed five 
electronic cigarette flavors (Tobacco, menthol, cherry, chocolate, no flavor), rating the most 
preferred flavor to least preferred flavor.  
 
Chemosensory Function 
The following variables were measured through survey questionnaires to assess self-rated 
chemosensory function. In addition, measured variables of chemosensory function were used in 
chapter three. Noted is if each variable is used in both, or one chapter.  
Self-reported olfactory function: NHANES questions are formulated to assess self-rated 
olfaction and taste function6 and used in both chapters. Participants were asked about perceived 
smell problems within the past 12 months [yes/no], phantom odor sensations [yes/no], and 
changes since age 25 in smell function [no change, better now, worse now]. Participants who 
answered ‘yes’ to either of the first two questions or ‘worse now’ to the last question were 
classified as having an olfactory alteration. This classification based on the three questions has 
proved to have test-retest reliability7 with fair sensitivity and specificity when compared with a 
single measure of olfactory function8. 
Self-reported taste function: This variable was examined only in chapter three. Based on the 
NHANES protocol, participants were asked about perceived problems in the past year, loss or 
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change in function since age 25, for taste (salt, sweet, bitter, sour) and for flavor (chocolate, 
vanilla or strawberry), as well as the presence of dysgeusia (taste things when nothing should be 
there) 6. Participants who answered ‘yes’ to problems, or ‘worse now’ since age 25 were 
classified as having a taste alteration.  
general Labeled Magnitude Scale (gLMS): All sensory intensity ratings described below for 
chapter three were made on the gLMS scale, which ranges from 0=nothing to 100=strongest 
sensation of any kind, with intermediate labels of 6=barely detectable, 17=moderate, 35=strong, 
and 53=very strong.  This scale generalizes ratings to all sensations, and has shown consistency 
with magnitude matching9, the gold standard for measuring perceived intensity.  
Measured Olfactory Function: A sixteen-item odor identification and intensity rating task was 
used to measure olfactory function. Participants were classified as anosmic/severe hyposmic (0-7 
odors identified correctly), hypsomic (8-12 identified correctly) or having a normal sense of 
smell (13-16 correctly identified). This was only examined in chapter three. 
Measured Taste Function:  Taste function was measured using the NHANES protocol10. 
Participants sampled concentrated quinine hydrochloride (QHCl - 1mM) as well as concentrated 
sodium chloride (NaCl - 1M and .32 M) drawn across the tongue tip and then sampled with the 
whole mouth.  Participants also reported the intensity of concentrated propylthiouracil (PROP - 1 
and 3.2 mM) sampled with the whole mouth. Intensity ratings on the gLMS scale were compared 
to a control group. This was measured only in chapter three.  
Measured Retronasal Function: Retronasal function was measured using a jelly bean test and 
included four jelly bean flavors (cherry, coffee, chocolate, and Tabasco®). Participants first rated 
the sweetness/flavor intensity of the jelly bean with their nose plugged using the gLMS. Then 
participants were told to unplug their nose and again rate the intensity of sweetness, flavor 
xi 
 
intensity, and level liking or disliking of the flavor on the gLMS. For the Tabasco® jelly beans, 
participants also rated the intensity of the burn or irritation feeling with the nose unplugged. 
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CHAPTER ONE 
 
INTRODUCTION 
1.1 Overview 
There are a total of four chapters in this thesis. Chapter one serves as an introduction to the 
research including specific aims and hypotheses. Chapter two and three report on studies of 
cigarette smokers and their chemosensory abilities, focusing on olfaction and taste. Specifically, 
chapter two reports on a secondary data analysis of the 2012-0214 National Health and Nutrition 
Examination Survey Data (NHANES), testing the classification of smoking status used to 
examine the association with self-reported olfactory alterations. Chapter three reports on baseline 
data from an NIH-funded Electronic Cigarette Study being conducted at UConn Health. The 
study population included male and female chronic cigarette smokers. Both chapters two and 
three include an introduction, methods, results, discussion, conclusion, and references sections. 
Chapter four serves as an overall conclusion, summarizing important results and implications for 
future research.  
 
1.2 Background 
The chemosenses refer to the sense of smell and taste, two sensory systems relied on by 
humans daily. The sense of smell functions through stimulation of the olfactory receptors by 
volatile chemicals that pass through the nasal cavity or the nasopharynx. Once at the receptors, 
olfactory neurons send the information to the central nervous system11. Odorants passing through 
the nasopharynx play a key role in flavor perception via retronasal olfaction, linking taste and 
smell together closely. Taste perception is mediated through taste buds located on the papillae of 
the tongue, which contain taste receptors to identify each of the unique five tastes (salty, sweet, 
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sour, bitter, and unami). Multiple nerves contact taste receptors throughout the tongue and throat 
to transfer taste information to the central nervous system11. Some differences in taste 
perception, specifically bitter taste perception, are second to polymorphisms in up to 26 different 
taste receptor genes, including the most studied TAS2R38 receptor gene 12. Additionally, taste 
perception plays a key role in flavor preference13, including influencing differences among 
smokers in choice of nicotine products, such as mentholated cigarettes or electronic cigarettes. 
Disorders or alterations of these senses include depressed/loss of smell (hyposmia, 
anosmia) and loss of taste (hypogeusia, ageusia), as well as distorted senses (parosmia) and 
phantom sensations (phantosmia)11. Alteration of the olfactory and/or taste systems has been 
linked to increased risk of exposure to hazards such as fire, fumes, or spoiled food14, as well as 
poorer dietary quality15 and reduced quality of life16,17. Olfactory dysfunction is more common 
than taste dysfunction, due to the redundancy of taste nerves that carry sensory information to the 
central nervous system, yet individuals often have trouble distinguishing the two dysfunctions18. 
Prevalence estimates of olfactory hyposmia/anosmia in population-based studies range from 
3.8% to 19.1%10,19,20. Taste hypogeusia/ageusia prevalence estimates are much less, with one 
study of a clinic population reporting 0.85% have true generalized taste loss21.  Taste changes are 
more likely to be localized to an area of taste nerve innervation, present as oral pain, and/or 
flavor changes as result of an olfactory dysfunction22,23.  
Main causes of olfactory and/or taste alteration include sinonasal conditions17, head 
trauma24, neurogenerative diseases25, upper respiratory tract infections23, aging26,27, as well as 
certain medications28,29. Alteration stems from changes or damage to receptors and the inability 
to transmit signals to the central nervous system30,31. Treatments for olfactory alterations vary 
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with the etiology, and include surgery or oral steroid use32-34. However, the outcome of many 
treatments, as well as the long-term effectiveness, is still largely unclear32.  
Because of the limitations of treatment for olfactory and taste alteration, prevention by 
limiting exposure to modifiable risk factors is an important avenue to explore. One modifiable 
risk factor that is a potential cause of olfactory and taste alteration is cigarette smoking. Cigarette 
smoking has remained a serious issue in the United States for decades. In 2014, an estimated 
16.8% of U.S adults were current smokers35. Of cigarettes sold in 2012, 31% were a mentholated 
brand36 and used more frequently by younger individuals and minority groups, specifically 
African Americans37. Although the detrimental effects of cigarette and tobacco use are well 
known, approximately 480,000 individuals die every year from smoking, and an additional 16 
million are living with a smoking related disease38 in the U.S. Additionally, 289 billion dollars 
are lost in the U.S. due to cigarettes each year, including 133 billion dollars from direct medical 
costs and over 156 billion dollars in lost productivity38. Healthy People 2020 has cigarette related 
goals and objectives, including reducing illness and death related to tobacco and second hand 
smoke exposure39.  
The U.S. Surgeon General report of the 50 Year Progress on Health Consequences of 
Smoking shows research over the decades has linked cigarette smoking to diseases in nearly all 
organs of the body38. It is a direct cause of several cancers, including lung cancer40, and is 
associated with heart disease41, chronic obstructive pulmonary disease42, diabetes43, rheumatoid 
arthritis44, and a weakened immune system45. Smokers have also reported significantly lower 
health-related quality of life compared to non-smokers. They are more likely to be heavy 
drinkers, report depressive symptoms, be less physically active, and have poorer intake of fruits 
and vegetables46. 
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Conflicting results of cigarette smoking on olfactory/taste alterations have been found in 
population and community-based studies. Several studies examining olfactory function in adults 
via standardized measured identification tests found no association between smoking and 
olfactory dysfunction19,47,48. However, other population-based studies have found smoking to be 
a risk factor for olfactory dysfunction, ranging from examining this relationship in current 
smokers and based on heaviness of smoking49,50. Similarly, studies have shown smokers to have 
altered taste function, however the type of alteration found varies between studies. Studies have 
found elevated taste sensations22 or greater taste thresholds51,52, as well as greater oral pain53 
among smokers. Conversely, a study examining risk factors for taste alterations and increased 
taste thresholds did not find an association with smoking54.  
There are several potential reasons for the conflicting findings of the association between 
cigarette smoking and olfactory/taste alterations, which points to the central aim of the current 
thesis. First, the way smoking is measured between studies is inconsistent. Population-based 
studies range in methods to characterize smoking as only current smokers to smoking heaviness 
by reported number of cigarettes or pack years (packs/day * years smoked). Second, measured 
function and single questions about olfactory/taste function do not always capture phantom 
sensations, and perceived changes in function with age, which both effect chemosensory abilities 
and must be accounted for. The NHANES 2012 results find smoking as a protective factor for 
olfactory function, but characterize smoking only as reported current, former, or never.  
Inconsistencies throughout population-based studies may account for varied findings in the 
literature. Cigarette smoking may require sophisticated characterization, probing further than 
current/former/never status. Additionally, olfactory and taste function must be measured 
comprehensively, both by self-report and measured function, in order to fully understand the 
- 5 - 
 
risks associated with altered functioning.  Finally, cigarette smoking is associated with other 
health behaviors and health risks, which also may combine to impact olfactory and taste 
function. Cigarette smoking is linked to heavier alcohol use55, as well as more frequent sinus and 
throat/mouth issues56-58. These unique and shared risks of being a cigarette smoker must be fully 
examined to understand the relationship with olfactory and taste alterations. 
 
1.3 Purpose 
The purpose of this research is to utilize a nationally-representative sample as well as a 
clinical sample of well-characterized cigarette smokers to improve the understanding of the 
chronic smoking effects on self-reported and measured olfactory and taste function. First, we 
assessed what measure of smoking in large population-based studies helped to best assess the 
relationship between smoking status and self-reported olfactory alteration and additional risk 
factors that contributed to the smoking-olfaction relationship, both directly and indirectly. 
Measures of smoking that captured chronic use, heaviness, and nicotine dependence were tested. 
Second, we aimed to assess olfactory and taste function of chronic smokers through objective 
measures, and assessed differences compared to non-smokers to determine variation among 
chronic smokers, specifically in regards to menthol status.  
 
1.4 Specific Aims 
1) To use the National Health and Nutrition Examination Survey (NHANES) 2011-2014 
data to assess the direct and indirect relationship between cigarette smoking and self-
reported olfactory alteration, testing different measures of smoking to determine the most 
helpful measure/combination of measures. 
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2) To use NHANES to assess what other olfactory-related risk factors and health behaviors 
(e.g., heavy alcohol use) contribute to the relationship between smoking and self-reported 
olfactory alteration.  
3) To use a well characterized clinical sample of cigarette smokers to assess measured 
olfactory and taste function and compare dysfunction rates to non-smokers and national 
prevalence estimates.  
4) To identify if the favorite flavor of electronic cigarettes of new electronic cigarette 
smokers was associated with their chemosensory function or use of mentholated 
cigarettes. 
 
1.5 Hypotheses 
1) Smoking is a risk factor for self-reported olfactory alteration, but the significance of 
findings will be based on the measure of smoking used. 
2) The most helpful measure of smoking to assess the relationship with self-reported 
olfactory alteration will include markers of chronic use (pack years), dependence (time to 
first cigarette), and biomarkers of heaviness (serum cotinine).  
3) The combination of smoking and heavy drinking will increase the odds of a self-reported 
olfactory alteration even greater than being a smoker alone.  
4) An indirect relationship will also exist between chronic smoking/smoking and drinking 
and self-reported olfactory alteration through known olfactory-related pathologies. 
5) Measured olfactory dysfunction, along with self-reported alteration, will be greater in 
chronic smokers, compared to general population estimates, and vary by menthol status. 
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6) Measured taste function of chronic smokers will show more impairment compared to 
non-smokers, and vary by menthol status.  
7) Electronic cigarette flavor preference will vary by menthol status or PROP taster profile. 
1.6 Significance 
The effects of cigarette smoking and taste/olfactory alteration have a significant impact on 
health, health care costs, and quality of life. The relationship between the two is still largely 
unclear due to inconsistent measures, which highlights the importance of further exploration. The 
significance of the research is first to provide insight into measures and characterization of 
smoking to understand those at highest risk for chemosensory alteration. Secondly, the findings 
from this thesis may provide information on additional benefits of smoking cessation as well as 
information on prevention of chemosensory function through avoiding chronic smoking. Finally, 
this research provides baseline chemosensory data of chronic smokers, allowing for examination 
of changes in function with smoking cessation. 
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CHAPTER TWO 
Cigarette Smoking’s Association with Self-reported Olfactory Alterations: Analysis of the 
2011-2014 NHANES. 
 
2.1 Abstract 
Background: Population-based studies show inconsistent effects of cigarette smoking on 
olfactory function. We aimed to identify direct and indirect associations between measures of 
smoking exposure/dependence and altered olfaction in a nationally-representative sample of 
adults. Methods: NHANES 2011-2014 (n=7,418) participants (mean age=57.8±12.2 years) self-
reported olfaction and related health and demographic risks. Affirmative answers to three 
questions defined altered olfaction (olfactory problems in past year, worse ability since age 25, 
phantosmia). Smoking (never, former, current) was self-reported by chronicity (pack years, PY) 
and dependency (time to first cigarette upon waking), and measured by serum cotinine. 
Associations were tested with logistic regression, reporting odds ratios (OR) and 95% confidence 
intervals (CI), and by mediation models. Results: Estimated prevalence of altered olfaction was 
22.3% and showed age-related increases. Nearly half of the sample was former/current smokers 
(47.4%). Controlling for olfactory-related risks, ≥10 PY smokers (current and former) had 
significantly greater odds of altered olfaction versus never smokers [OR 1.36, CI: 1.06-1.74]. 
Current smoking with ≥10 PY failed to show greater odds of altered olfaction unless they 
smoked within 30 minutes of waking [OR 1.41, CI: 1.01-1.99]. Light smokers (≤10 PY smokers) 
did not show increased odds versus never smokers. Current smokers who also were heavy 
drinkers (≥4 drinks/day) had greatest risk for altered olfaction (OR 1.96, CI: 1.20-3.19). 
Olfactory-related pathologies (sinonasal problems, serious head injury, tonsillectomy, 
xerostomia) partially-mediated the association between smoking and altered olfaction. 
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Conclusion: Chronic cigarette smoking was associated with increased risk of self-reported 
olfactory alterations, directly and indirectly via olfactory-related pathologies.   
 
2.2 Introduction  
According to the National Health and Nutrition Examination Survey (NHANES) 2011-
2012, olfactory dysfunction is a prevalent problem, affecting nearly 13%1 of U.S adults ≥40 
years of age based on performance on odor identification and 23%2 by self-report.  Olfactory 
dysfunction can range from partial (hyposmia) to complete (anosmia) loss, as well as alterations 
perceived with age and phantom olfactory sensations2.  Olfactory dysfunction may result from 
changes to the olfactory receptors, inability of odors to reach and bind these receptors, 
interrupted transmission of odors from the periphery to the central olfactory systems, or inability 
to correctly identify and label odors3. As shown in clinical and population-based studies2,4-7, 
common causes of olfactory dysfunction include frequent sinonasal problems8, trauma to the 
head or face9, exposure to certain chemicals10, medications11, neurodegenerative disorders12, and 
advanced age13. Individuals with olfactory dysfunction have greater risk of hazardous exposure 
related to depressed ability to detect warning signs of fire, fumes, leaking gas, or spoiled foods14.  
They can suffer from poorer dietary quality and nutritional status15,16, as well as reduced quality 
of life17. Healthy People 2020 has added chemosensory disorder-related goals, including 
increasing the proportion of adults who seek diagnosis and treatment for these disorders18. With 
growing attention to olfactory function, screening, assessment and treatment options should be 
expanded (e.g.19-22). 
Olfactory dysfunction could be prevented by limiting modifiable risk factors. One 
potential modifiable risk factor is cigarette smoking. In animal models, chronic exposure to 
aqueous cigarette smoke decreases functional olfactory receptor neurons23.  However, these 
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findings have not been consistently generalized to large community and population based 
studies. Baseline results from the Epidemiology of Hearing Loss Study indicated that current 
smokers (relative to former and never smokers) had greater odds of olfactory dysfunction by 
odor identification task 4, yet the 5-year follow-up found no significant association between 
baseline smoking status and incidence of olfactory dysfunction24.  A cross-sectional population-
based study of 1,300 Swedish adults found no association between measured odor identification 
ability and cigarette smoking, whether defined as current smoking, heavy smoking, or pack 
years25.  Yet a cross-sectional population based study in Spain (n=9,348) utilizing self-
administered odor identification task and self-reported function, found that former or current 
smoking was a mild protective factor for olfactory function5. Conversely, a population-based 
study in Germany of 1,312 individuals found current smoking to be a risk factor for measured 
olfactory dysfunction, with a dose-response relationship between cigarettes/day smoked and 
frequency of impairment26.  Similarly, a dose-response relationship was reported between 
chronic smoking and odor impairment in a community-based study of 638 adults 27, yet the 
combined effects of other olfactory-related risk factors on this association was not tested. A 
recent clinical study also identified greater levels of olfactory dysfunction in chronic smokers 
(thoroughly characterized for smoking behaviors) than that found in a nationally-representative 
sample of U.S. adults 28. 
Long-term cigarette exposure also may have an indirect effect on olfactory function 
through other known risk factors for dysfunction including upper respiratory track infections29, 
sinonasal problems30,31, and dry mouth (xerostomia)32. Smokers may be more susceptible to 
developing viral respiratory colds 33. A comprehensive review also found that smoking was 
associated with acute and chronic rhinitis and increased nasal inflammation34. Additional studies 
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have found smokers more likely to experience xerostomia35, 36. These same risk factors 
associated with increased risk of olfactory alteration in NHANES 2011-2012. Significant risk 
factors for self-reported olfactory alteration were persistent cold/flu, persistent xerostomia, 
frequent nasal congestion, and history of head injury as well as heavy alcohol consumption2. 
Greater alcohol consumption has been noted among smokers 37. Excessive alcohol consumption 
has been linked to depressed olfactory function measured by odor identification38 and/or odor 
discrimination39,40, and dysfunction has been noted among those with Korsakoff Syndrome (a 
neurological complication of alcohol dependence)41.  
Using the NHANES 2011-2014 data, the goal of the present study was to examine the 
independent and joint effects of smoking status and other olfactory-related risk factors on self-
reported olfactory alteration in a nationally-representative sample of U.S adults 40 years and 
older. The majority of studies to date have examined only self-reported current, never, or past 
smoking. Here, we examined measures of self-reported smoking exposure including chronicity 
(duration and amount smoked captured in pack years), as well as time to first cigarette of the day 
(TTFC), which serves as a proxy for nicotine dependence that links with negative health 
outcomes42,43.  Additionally, we defined current smoking (at the time of the NHANES 
assessment) by serum cotinine, the main metabolite of nicotine, which is regarded as the best 
biomarker of smoking status and exposure44. We hypothesized that defining smoking status by 
chronicity, dependence and a nicotine biomarker would strengthen its association with self-
reported olfactory alteration. We also hypothesized a synergistic effect of dependent smoking 
and heavy alcohol consumption on olfactory alteration. Finally, we hypothesized that smoking 
would have an indirect effect on self-reported olfactory alteration through other olfactory-related 
pathologies (e.g., sinonasal problems).  
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2.3 Methods: 
2.3.1 NHANES Data Source and Participants 
The NHANES is conducted each year by the National Center for Health Statistics 
(NCHS) of the Centers for Disease Control and Prevention (CDC). The survey utilizes cluster, 
multistage sampling to randomly select households from across the United States. The sample is 
nationally representative of civilian, non-institutionalized residents, selected for assessment of 
health and nutrition via interview questionnaires, laboratory tests and physical examinations. The 
data collected give insight to emerging health issues, risk factors for diseases, and changes in 
health problems over time45. 
For this study, the continuous NHANES 2011-2012 and 2013-2014 waves were merged 
and adults, aged 40 years and older (n=7418) who answered questions on olfactory-related 
problems, cigarette smoking, and other potential risk factors, were included in the analysis. The 
NCHS Research Ethics Review Board approved all procedures. All participants provided 
written, informed consent. 
 
2.3.2 Measures 
Chemosensory (CSQ) Questionnaire  
The NHANES CSQ questions were formulated to capture perceived taste and olfactory 
function. The olfactory-related questions included self-reported ability, symptoms and medical 
treatment for dysfunction, and presence of any related risk factors for dysfunction. Affirmative 
responses to three questions were used to define self-reported olfactory alteration: perceived 
olfactory problems within the past 12 months [yes], phantom odor sensations [yes], and 
perceived changes in function since age 25 [worse now]. This index of self-reported olfactory 
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alteration has proved reliable46 with 54.4% sensitivity and 78.1% specificity for identifying 
anosmia/severe hyposmia1. The dichotomous measure [‘yes’ or ‘no’] for self-reported olfactory 
alteration was the outcome variable in data analyses in the present study. 
 
Cigarette Smoking  
The smoking portion of the NHANES home interview included questions about daily 
cigarette use, history of use, and related details including length of time being a smoker and time 
to first cigarette upon waking in the morning47. Serum cotinine was measured as part of the 
laboratory procedure in the NHANES mobile examination center. The interview responses and 
cotinine levels were used to formulate five classes of smoking status (Table One). 
Smokers were classified based on an affirmative response to ever smoking 100 cigarettes 
in their lifetime; never-smokers answered “no.” Current smokers answered “yes” to the question 
“do you now smoke cigarettes” whereas former smokers answered “no”. Former smokers also 
reported the length of time since quitting cigarettes, which was converted into a continuous 
measure (years, portion of years). 
Packs smoked per year (packs/day X years smoked) defined smokers as light (<10 pack 
years, n=1,343) or chronic (≥ 10 pack years, n=1,922) smokers. Chronic smokers were classified 
further as current (n=915) or former (n=1,007). Years smoked was calculated for current 
(interview age – age reported started smoking) and former [interview age – (age reported started 
smoking – reported number of years since quitting)] smokers.  
Adding a proxy for nicotine dependence, smoking status was further defined by 
incorporating time to first cigarette of the day (TTFC).  Current chronic high dependent smokers 
were defined as ≥10 PY and time to first cigarette (TTFC) within thirty minutes of waking 
(n=582). Light smokers were either <10 PY or did not smoke within thirty minutes (n=697). PY 
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also was combined with the available cotinine measure from the NHANES 2011-2012 subset. 
Typical levels among non-smokers are <1 ng/mL and those with heavier exposure (e.g., 
secondhand smoke) are 1-10 ng/mL44. In the current study we used a level of ≥10 ng/mL 
cotinine to define a smoker48 and to distinguish false self-reports of non-smoking. Thus, chronic 
active smokers were defined as ≥10 PY smokers with cotinine levels ≥10ng/mL (n=418) and 
current light smokers were <10PY or had <10 ng/mL cotinine (n=422). Never/former smokers 
were defined as having serum cotinine <10 ng/mL. Because cotinine metabolism varies between 
race/ethnicity groups49, multivariate analyses were also verified using race/ethnicity-specific 
cotinine exposure levels 50.   
Smoking status also was defined with TTFC and available cotinine levels to compare to 
never/former smokers who had cotinine <10 ng/mL. High dependent active smokers reported 
TTFC within thirty minutes of waking and had cotinine levels ≥10ng/mL (n=297); light smokers 
did not smoke within thirty minutes (n=450) or had <10 ng/mL cotinine (n=450).  
 
Alcohol Consumption 
The alcohol use questionnaire was asked in the NHANES examination and probed both 
current and lifetime alcohol use trends. A heavy drinker was defined as reporting current or 
history of drinking ≥4/5 drinks on most/every day [yes/no]. This variable was examined 
independently as a risk factor for olfactory alteration as well as combined with  high dependent 
smoking, defined as <30 minute TTFC. Adults were classified as either never/former smoker and 
heavy drinker (n=628), high dependent smoker and non-heavy drinker (n=391), or high 
dependent smoker-heavy drinker (n=214) to compare with neither smokers nor heavy drinkers 
(n=4,642).  
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Table One: NHANES smoking status class definitions and comparison groups 
Smoking status 
measure 
Measure definition 
Adults (n=) in smoker group 
versus comparison group 
Chronic Smoker 
 
(≥10 PY Smokers) 
Current or former chronic 
smokers based on ≥10 PY (packs 
smoked per day * years smoked); 
Former/current light smokers <10 
PY 
Chronic smokers (915 current and 
1,007 former) or light smokers 
(1,343 ) versus  never smokers 
(3,942) 
Current Chronic High 
Dependent Smoker 
 
(≥10 PY, <30 minutes 
TTFC smokers) 
Current chronic high dependent 
smoker based on ≥10 PY who 
report smoking within 30 minutes 
of waking (TTFC); Current light 
smoker based on <10 PY or >30 
minute TTFC 
Current chronic dependent 
smokers (582) or current light 
smokers (697) versus 
never/former smokers (6,058) 
Chronic Active 
Smokers 
 
(≥10 PY, ≥ 10 cotinine 
smokers*) 
Chronic active smokers based on 
≥10 PY smokers who also have 
cotinine levels ≥10 ng/mL; 
Current light smokers based on 
<10 PY or cotinine <10 ng/mL 
Chronic active smokers (418) or 
current light smokers (422) versus 
never/former smokers (2,468 ) 
High Dependent 
Active Smokers 
 
(<30 min TTFC, ≥ 10 
cotinine smokers*) 
High dependent active smokers 
based on  reporting smoking 
within 30 minutes of waking 
(TTFC) and cotinine levels ≥10 
ng/mL; Current light smokers 
based on >30 minute TTFC or 
cotinine <10 ng/mL 
High dependent active smokers 
(297) or Current light smokers 
(450) versus never/former 
smokers (2,468) 
High Dependent 
Smoker-Drinker  
 
(<30 min TTFC 
smoker and heavy 
drinker) 
Dependent smokers (<30 minutes 
TTFC) and who report having 
≥4/5 alcoholic drinks on 
most/every day 
High dependent smokers-drinkers 
(214) or never/former smokers 
and drinkers (628) or smokers and 
non-drinkers (391) versus 
never/former smokers and non-
drinkers (4,642) 
*Mean cotinine levels by smoker classification (ng/ml) 
Chronic Active Smokers: Never/former 0.13±0.73, Light 148.52±125.82, Chronic Active 265.89±138.05  
High Dependent Active Smokers: Never/former 0.13±0.73, Light 193.24±133.68, Dependent Active 275.15±129.66 
 
Olfactory-related Pathologies and Socio-demographic Risk Factors 
A number of potential risk factors of olfactory alterations were assessed and examined as 
covariates, including socio-demographic variables and olfactory-related pathologies. Education 
status was dichotomized to below a high school education or high school education and above. 
Race was classified as Mexican American, Other Hispanic, Non-Hispanic white, Non-Hispanic 
black, Non-Hispanic Asian, or Other Non-Hispanic/Multi-Race. Income to poverty ratio (family 
income divided by federal poverty threshold) also was dichotomized as below (≤ 1) or above 
(>1) the poverty line. Marital status was defined as married or not (widowed, divorced, 
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separated, or never married). Self-rated health status was dichotomized to poor/fair health or 
excellent/very good/good health. A sinonasal problem was defined as report of persistent cold/flu 
or frequent nasal congestion in the past twelve months.  Other examined risk factors included 
xerostomia (persistent dry mouth) during the past twelve months, history of serious head or face 
injury, history of tonsillectomy, and history of frequent ear infections (3 or more).  
 
2.3.3 Data Analysis 
The NHANES 2011-2014 data set is publicly available for secondary analysis. Because 
of the complex sampling design, sample weights were combined between waves and used to 
account for over-sampling, survey non-response, and post-stratification. Statistical analyses were 
completed using SAS version 9.4 (Cary, NC). All tests were two-tailed and p-values <0.05 were 
considered statistically significant.  
Univariate associations between self-reported olfactory alterations and potential risk 
factors were assessed with chi square tests for categorical variables and two-tailed t-tests for the 
age continuous variables. Only chronic/dependent/active smokers, the population of interest, 
were compared to never/former smokers in univariate analysis. Post-hoc analysis was completed 
for chi-square tests when necessary using adjusted standardized residuals51. Potential risk factors 
for self-reported olfactory alteration, including all levels of smoking status, were examined in the 
unadjusted and adjusted logistic regression models. Odds ratios were considered significant if the 
confidence interval did not include the value one, and risk factors significant in the unadjusted 
model were included in the multivariable (adjusted) models.  Separate multivariable models were 
tested for each smoking status class (Table One). Former smokers were grouped with never 
smokers for the analyses, except for the >10 PY (chronic) measurement, as the former group did 
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not have significantly greater risk of olfactory alteration compared to never smokers (results not 
shown). For the smoking status classes including cotinine, only the NHANES 2011-2012 wave 
was available. Due to unequal sample sizes of non-smokers versus chronic active/high dependent 
active smokers, logistic regression tests were verified using age and sex matched nonsmokers to 
smokers. Matching was completed using propensity scores via the MatchIt package in R 
(www.r-project.org).  
Mediation models were completed in SPSS using the PROCESS macro.  Two models 
were examined based on the smoking variables that explained the greatest odds of self-reported 
olfactory alteration in multivariable analysis (current chronic high dependent smokers, high 
dependent smoker-drinkers). Several other models and directionality of variables were tested 
with the displayed models best capturing the data and relationships. The mediator variable was 
an olfactory risk score comprised of the significant risk factors for olfactory alteration in the 
multivariable analysis, scored from zero to five based on “yes” responses to frequent nasal 
congestion, persistent cold/flu, xerostomia, tonsillectomy, or history of a serious head/face 
injury. The first model tested whether the olfactory risk score (m) mediated the association 
between current chronic high dependent smoking (x) and olfactory alteration (y). The second 
model tested whether the olfactory risk score (m) mediated the association between high 
dependent smoker-drinkers (x) and olfactory alteration (y). In the mediation models, the a paths 
represent the relationship between x and m, and the b paths represent the relationship m and y. 
The product of path a and b represents the indirect effect of chronic dependent smoking or 
dependent smoking-drinking on olfactory alteration; the c’ path represents the direct effect on 
olfactory alteration. Path c, or the total effect, equals the direct plus the indirect effects. 
Equations between all variables were tested prior to running mediation modeling to test for 
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expected bivariate relationships between x and y, between x and m, and between m and y, 
controlling for x. Beta estimates, standard errors, and 95% confidence intervals were used 
through bootstrapping procedure using 5,000 resampling to estimate the mediation relationships. 
Relationships were considered significant if the confidence intervals did not include the value 
zero. The ratio of the indirect effect to the total effect was used to quantify the proportion 
mediated. Cases containing missing data were excluded in the analysis and covariates included in 
both models were age, sex, race and income-to-poverty ratio. 
 
2.4 Results 
Of the sample, 52.3% were never smokers, and 47.4% were former/current smokers. 
Table Two provides demographic characteristics of the total sample and by smoking status class.  
The mean age of the total sample was 57.8 ± 12.2 years and 47.2% were males.  Most adults 
reported living above the poverty line and completing high school or above. Smokers, defined by 
all five classes, were more frequently male, non-Hispanic White, had lower education level, 
lived below the poverty line, and were heavy drinkers.   
Of the total sample, 22.3% (n=1609) reported an olfactory alteration. Of those with an 
alteration, 32.4% reported loss since age 25 and 26.2% reported both a problem in the past year 
and loss since age 25. Among those who reported olfactory alterations, 6.5% reported all three 
olfactory-related problems (problems in past year, loss with aging, phantosmia) whereas 20.4% 
reported phantom sensations only (without reporting loss with age or smell problems). These 
results are comparable to prevalence estimates in the NHANES 2011-20122. 
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Table Two: Demographic characteristics of participants in the NHANES 2011-2014 sample 
and stratified by smoking status class 
 
Entire 
NHANES 
sample 
Current 
and 
Former 
Chronic 
Smokers  
Current 
Chronic 
High 
Dependent 
Smokers 
Chronic 
Active 
Smokers 
High 
Dependent 
Active 
Smokers 
High 
Dependent 
Smoker-
Drinkers 
Number of 
Participants 
7418 1922 582 418 297 214 
Gender (%) 
 
     
       Male 47.2 56.6 53.7 58.4 54.5 70.6 
      Female 52.8 43.4 46.4 41.6 45.5 29.4 
Age (years) 57.8 ± 12.2 59.4 ± 11.6 59.8 ± 9.6 54.5 ± 10.5 54.0 ± 10.2 53.2 ± 8.8 
Race (%) 
 
     
     Mexican American 6.2 3.1 1.1 1.9 2.4 1.8 
    Other Hispanic 4.9 3.0 2.7 2.5 2.2 1.9 
   Non-Hispanic white  71.2 79.9 80.5 79.1 76.5 81.7 
    Non-Hispanic black 10.7 9.0 9.5 9.6 11.3 10.3 
   Non-Hispanic Asian 4.8 2.0 1.1 1.0 1.1 <1 
   Other/Multi-Race 2.2 3.0 5.1 5.8 6.5 4.0 
Education (%) 
 
     
      < High school 17.1 21.2 27.5 24.6 26.6 32.7 
      ≥High school  82.9 78.8 72.5 75.4 73.4 67.3 
Income to Poverty 
Ratio (% ≤1)  
12.9 15.6 25.5 17.9 23.1 30.8 
Marital Status 
 
     
     Married (%) 63.2 56.6 49.9 51.4 46.9 48.3 
Heavy Drinkers (%) 15.5 30.5 37.4 33.6 32.7 100 
 
2.4.1 Risk factors associated with olfactory alteration examined by univariate analysis 
Table Three reports distribution of olfactory alteration by separate potential risk factors, 
including the five smoking status classes defined above. There was no significant difference in 
prevalence of olfactory alteration between males and females, however adults 80 years and older 
most frequently reported olfactory alteration. Post-hoc testing showed that a significantly higher 
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proportion of Non-Hispanic White and Other Non-Hispanic/Multi-Race reported olfactory 
alteration while fewer Non-Hispanic Black and Asians reported alteration. Adults who were not 
married, lived below the poverty line, had self rated fair/poor health, or were heavy drinkers had 
significantly greater reported frequency of olfactory alteration. Additionally, greater frequency of 
olfactory alteration was reported by those with history of serious head/face injury, tonsillectomy, 
ear infections, persistent cold/flu, dry mouth, and frequent nasal congestion. These significant 
risk factors are consistent with the NHANES 2011-2012 analysis2. Among the five classes of 
smokers, a greater frequency of the smokers reported an olfactory alteration compared to 
never/former smokers.  Current chronic high dependent smokers reported olfactory alterations 
most frequently at 32.8%.  
The unadjusted odds ratios and 95% CI for these risk factors also were examined prior to 
multivariable analysis to determine significant factors to be included in final adjusted models 
(see Supplemental Materials). Significant risk factors included age, not being married, income 
to poverty ratio ≤1, sinonasal problems, xerostomia, head/face injury, tonsillectomy, multiple ear 
infections, self-rated fair/poor health, and smoking (not light smoking) defined by all five classes 
in Table One.  
Table Three: Distribution of self-reported olfactory alteration by each potential risk factor 
 
Total 
Sample 
Reported 
Olfactory 
Alteration 
% of Self-reported Olfactory 
Alteration 
  N N % Yes % No 
Test 
Statistic and  
P-value 
Age, years (mean) 
57.8 
±12.2 
 58.6 ±12.4 
57.6 ± 
12.2 
T=2.13, 0.04 
Age strata     
x2=16.10, 
0.03 
   40-49 years 1,934 378 20.4 79.6  
   50-59 years 1,852 402 22.8 77.2  
   60-69 years 1,848 406 22.3 77.7  
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   70-79 years 1,069 216 22.1 77.9  
   80+ years 715 207 28.3 71.7  
Sex     
x2= 0.28, 
0.87 
   Male 3,556 747 22.4 77.6  
   Female 3,862 862 22.2 77.8  
Race/Ethnicity     
x2=30.52, 
0.001 
   Mexican-American 803 172 21.3 78.7  
   Other Hispanic 737 162 21.9 78.1  
   Non-Hispanic black 1,777 351 19.4 80.6  
   Non-Hispanic white 3,047 761 23.2 76.8  
  Non-Hispanic Asian 894 118 13.1 86.9  
   Other/Multi-Race 160 45 30.9 69.1  
Marital Status     
x2=10.32, 
0.001 
   Married 4,301 844 21.0 79.0  
   Not Married 3,108 762 24.3 75.7  
Education     
x2=2.58, 
0.23 
   < High school  1,925 433 24.0 76.0  
   ≥High school 5,484 1,176 22.0 78.0  
Income-to-poverty ratio     
x2=16.71, 
0.0001 
   IPR ≤1 (poverty) 1,426 377 27.9 72.1  
   IPR > 1  5,322 1,112 21.7 78.3  
Self-rated health     
x2=50.20, 
0.0001 
 Fair or poor 1,793 514 30.0 70.0  
    Excellent, v. good, good 4,704 924 20.8 79.2  
Heavy Alcohol Use     
x2=55.91, 
<0.0001 
  Yes 
  No 
986 281 31.8 68.2  
5,464 1,142 21.0 79.0  
Current & Former 
Smokers 
     
  Chronic Smokers 
  Never-smokers 
1,922 
3,942 
544 
725 
29.3 
19.1 
70.7 
80.9 
x2=77.82, 
<0.001 
  Current Smokers      
  Chronic High Dependent Smokers  
  Never/former smokers 
582 
6,058 
181 
1,243 
32.8 
21.2 
67.2 
78.8 
x2=44.96, 
<0.001 
     Chronic Active Smokers 
 Never/former smoker 
418 
2,468 
134 
542 
30.6 
22.0 
69.4 
78.0 
x2=15.98, 
0.048 
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 High Dependent Active Smokers 
 Never/former smoker 
297 
2,468 
97 
542 
31.3 
22.0 
68.7 
78.0 
x2=13.99, 
0.04 
High Dependent Smoker-drinkers 
Never/former smoker, non-drinker 
214 
4,642 
70 
936 
37.6 
20.5 
62.4 
79.5 
x2=37.37, 
<0.0001 
Olfactory-related risk 
factors 
  “Yes,” have ever had… 
     
   Serious head/face injury 1,573 465 28.2 71.8 
x2=53.26, 
0.0001 
   Ear infections, 3+ times 1,397 423 27.8 72.2 
x2=44.67, 
0.0001 
  Tonsils removed 1,853 476 26.0 74.0 
x2=28.23, 
0.001 
  “Yes,” in last 12 months      
    Cold/flu for >1 month 478 182 38.8 61.2 
x2=76.22, 
0.0001 
    Persistent dry mouth 1,115 424 37.5 62.5 
x2=149.82, 
0.0001 
   Frequent nasal congestion 2,055 671 32.2 67.8 
x2=168.09, 
0.0001 
 
 
2.4.2 Examination of smoking status as a risk factor for olfactory alteration by multivariable 
analysis 
The adjusted models were tested with each class of smoker. Significant independent risk 
factors of olfactory alteration in all models include sinonasal problems and xerostomia. The 
significance of other risk factors (history of a serious head/face injury, tonsillectomy, poor self-
rated health, heavy alcohol use, poverty) varied between the adjusted models. In former smokers, 
a greater number of years since quitting smoking was not associated with lower odds of an 
olfactory alteration when controlling for age and sex (OR: 1.00; CI: 0.99-1.01).  
In fully adjusted models, smoking status measured by PY alone and TTFC with PY 
remained significant risk factors for olfactory alteration (Figure One: Model A-D).  Model A 
found that chronic smokers (former and current) versus never-smokers were at significantly 
greater odds of olfactory alteration (1.36, CI: 1.06-1.74). However, when former and current 
chronic smokers were examined separately (Model B) in the adjusted model, only former chronic 
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smokers remained at significantly greater odds (1.42, CI: 1.09-1.84) and current chronic smokers 
did not (1.29, CI: 0.93-1.80). TTFC <30 minutes was not a significant risk factor alone (1.30, CI: 
0.94-1.79), but current chronic high dependent smokers were at significantly greater odds of an 
olfactory alteration versus never/former smokers (1.41, CI: 1.01-1.99) (Model C). No significant 
difference in odds of an alteration was seen between light smokers and never/former smokers in 
any model. 
The cotinine biomarker as a measure of current smoking status did not add predictive 
ability. There was non-significant greater odds that chronic active smokers [1.22, CI: 0.72-2.05] 
or high dependent active smokers [1.22, CI: 0.77-1.93] had olfactory alteration versus 
never/former smokers. Chronic active smokers and high dependent active smokers compared to 
age and sex matched never/former smokers were also not at increased odds of an olfactory 
alteration. Furthermore, cotinine alone as a continuous measure of smoking, or by race specific 
cut-off points, was not a significant risk factor for olfactory alteration.  
High dependent smoker-drinkers were at the greatest risk for olfactory alteration than any 
of the smoking measures alone (1.96, CI: 1.20-3.19) (Model D). Being a dependent smoker and 
non-heavy drinker or non-smoker and heavy drinker were not significant risk factors. All 
smoking variables were tested with heavy alcohol use; TTFC with heavy alcohol produced the 
highest odds ratios with olfactory alteration. 
Figure One: Forest plots of adjusted odds ratios and 95% confidence intervals of risk 
factors associated with self-reported olfactory alteration in U.S adults in models examining 
A) Current and former chronic smokers  B) Chronic smokers stratified by current and 
former  C) Current chronic high dependent smokers  D) High dependent smokers-drinkers 
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2.4.3 Examination of the indirect relationship with olfactory alteration through mediation 
modeling 
Table Four and Figure Two display the two mediation models, beta estimates with 95% 
confidence intervals of pathways, indirect, and direct effects when controlling for age, gender, 
race/ethnicity, and poverty. The first model displays the indirect relationship between current 
chronic high dependent smokers with olfactory alteration through olfactory risk score. All of the 
beta estimates (path a and b) were positive, suggesting that with moving from never/former 
smokers to chronic high dependent smokers, there was greater number of olfactory risk factors, 
which resulted in greater risk of olfactory alteration. Both the direct and indirect effects were 
significant (0.3786, CI .1707-.5865; 0.1043, CI: .0611-.1538) indicating partial mediation. Of the 
relationship between smoking and olfactory alteration, 21.6% was mediated via olfactory risk 
factor score. 
The second model showed similar, but more significant results. Moving from a 
never/former smoker and non-drinker to a high dependent smoker-drinker was associated with 
greater olfactory risk factor score, which was associated with greater risk of olfactory alteration. 
The direct (0.3651, CI: .0373-.6929) and indirect (0.1884, CI: .1155-.2767) effects were both 
significant. Of the relationship between smoking-drinking and olfactory alterations, 34.0% was 
mediated via olfactory risk factor score.  
 Table Four: Beta estimates, standard error, and 95% confidence intervals of the mediation 
relationship of smoking/smoking and heavy drinking relationship with self-reported 
olfactory alteration 
Relationships Estimate Standard Error CI 
Chronic high dependent 
smokingolfactory risk score (a) 
0.234 0.045 0.147-0.322 
Olfactory risk scoreolfactory 
alteration (b) 
0.445 0.031 0.384-0.507 
Chronic high dependent 
smoking olfactory alteration (c’) 
0.379 0.106 0.171-0.587 
Indirect Effect 0.104 0.024 0.061-0.154 
†Covariates controlled for include age, gender, race/ethnicity, and poverty 
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Relationships Estimate Standard Error CI 
High dependent smoker-
drinkerolfactory risk score (a) 
0.426 0.069 0.290-0.562 
Olfactory risk scoreolfactory 
alteration (b) 
0.442 0.038 0.367-0.517 
High dependent smoker-drinker 
olfactory alteration (c’) 
0.365 0.167 0.037-0.693 
Indirect Effect 0.188 0.040 0.116-0.277 
†Covariates controlled for include age, gender, race/ethnicity, and poverty 
Figure Two: Models of the association between (A) chronic high dependent smoking or (B) 
high dependent smoking-drinking and self-reported olfactory alterations mediated by 
olfactory risk score in data from the National Health and Nutrition Examination Survey 
2012-2014. 
 
 
2.5 Discussion 
With the addition of the Healthy People 2020 chemosensory goals and the data from the 
new chemosensory protocol in the NHANES 2011-2104, alterations in the sense of smell are 
A. 
B. 
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gaining more attention as a prevalent health problem. Analysis of the 2011-2012 and 2013-2014 
waves revealed an estimated prevalence of altered olfaction at 22.3% across U.S adults ages ≥40 
years, including problems in the past year, loss since age 25, and/or phantom olfactory 
sensations. This prevalence is nearly equivalent to the initial estimates from 2011-2012 
NHANES (23%) 2. Compared with never/former smokers, a significantly greater frequency of 
smokers reported an olfactory alteration, ranging from 29.3-32.9% depending on how smoking 
was characterized.  High dependent smokers who also were heavy alcohol drinkers had the 
highest frequency of self-reported olfactory alteration at 37.6%. The association between chronic 
high dependent smoking or dependent smoking-drinking and olfactory alteration was partially 
mediated (21.6-34%) by an olfactory risk score, comprised of pathologies associated with 
olfactory dysfunction (frequent nasal congestion, persistent cold/flu, presence of xerostomia, 
tonsillectomy, or history of a serious head/face injury).  
The estimated prevalence of self-reported olfactory alteration is almost double that of 
measured olfactory dysfunction at 12.4%1 from the initial analysis of the 2012 NHANES.  The 
self-report measure captures perceived changes in function with aging as well as phantosmia, 
neither of which are captured with a single measurement of olfactory function52.  In contrast, two 
previous population-based studies reported greater measured olfactory dysfunction at 19-24.5% 
among adults than that with a single question about self-reported olfactory problems at 9.5-
15%4,25. Based on previous analysis, all three questions used in the olfactory alteration index 
contributed to the prevalence estimated and showed a sensitivity of 54.4% (correctly identifying 
dysfunction) and a specificity of 78.1% (correctly identifying normal function) when compared 
with measured anosmia/severe hyposmia1. The NHANES olfactory alteration index also 
associated significantly with previously identified risk factors for olfactory dysfunction2, 
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including sinonasal problems8,24, xerostomia53, history of a serious head/face injury9, 
tonsillectomy54, and poverty55. This self-report measure may be more beneficial than measured 
olfaction for the current study, as we were examining chronic cigarette use, and not just current 
use. The perceived changes in olfactory function over time are therefore important to capture, 
and measured testing does not have the ability to pick this up, or the ability to detect phantom 
sensation, both which contribute to olfactory issues. As previously2, we did not observe that 
males self-reported higher rates of altered olfaction, in contrast to gender differences observed 
with measured function in NHANES 2012 (males 3 times more likely to have severe 
hyposmia/anosmia than females1), or other population-based studies 5,25. 
Interestingly, in the recent analysis of the NHANES 2011-2012 olfactory data, cigarette 
smoking appeared as a protective factor for measured olfactory function1 and had a non-
significant effect on self-reported olfactory function2. However, in the current analysis, cigarette 
smoking was a risk factor for self-reported olfactory alteration, when characterized by chronicity 
(≥10 PY), dependency (time to first cigarette <30 minutes) and when combined with heavy 
drinking. The chronicity of smoking measured in pack years (≥10 PY) significantly increased 
odds of self-reported olfactory alteration in former and current smokers when examined together, 
but not in current chronic smokers alone.  In current smokers, those who were both chronic and 
dependent smokers were at an increased risk for olfactory alteration versus never/former 
smokers. Pack years or TTFC alone as a measure of current smoking did not associate with an 
increased risk of olfactory alterations, and these measurements had to be looked at together to 
see increased odds.  
To our knowledge, only four other studies have used pack years as a measure of smoking 
in examining the association with olfactory function. One study found no association with 
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olfactory dysfunction when examining pack years in former and current smokers, or heavy use 
(>20 cigarettes/day) among current smokers25. However the other three studies found a dose-
related response with pack years in current smokers, who had increased olfactory thresholds56, as 
well as a worse odor discrimination and odor identification27,57. These previous studies, however, 
did not control for as many other known risk factors in multivariable analysis as done in the 
present study (e.g., sinonasal issues, head trauma, xerostomia). None of the existing studies have 
used time to first cigarette as a measure of smoking to examine olfactory alterations. This 
measure has been used to examine numerous other outcomes, such as quitting success58, 
hypertension59 and COPD or pulmonary impairment43,60. TTFC corresponds well with 
biomarkers of smoking, such as nicotine, cotinine, and hydroxycotinine concentrations61 and is a 
fast and inexpensive measure of nicotine dependence. The results from the present study suggest 
that it is important to characterize smoking thoroughly, capturing chronicity (PY) and 
dependency (TTFC), to accurately assess risk for olfactory alteration.  
We did not find an association with years since quitting smoking and improvement in 
olfaction in former smokers, as observed by Frey et al 27. One potential reason for the lack of 
findings in the present study could be the older age of our sample. Frey et al examined 
participants aged 17 to 69 (mean age 42.9 years), compared to the present study’s mean age of 
57.8 years. Advanced age is known to be associated with decreased smell function13. An increase 
in years since quitting is also accompanied by an increase in age, which may counter the positive 
effects of quitting on olfactory function, resulting in an insignificant finding.  In addition, the 
Frey et al study did not control for other demographic and pathology-related risks for olfactory 
dysfunction. 
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Although TTFC measure has been shown to associate with cotinine levels, using serum 
cotinine as a measure of smoking status did not strengthen its association with self-reported 
olfactory alteration in this study. Cotinine was verified by race-specific cut off points, however 
there is still not a universal cut-off point verified to distinguish smokers and non-smokers, or 
heaviness of smoking. A systematic review examining 67 studies that measured self-reported 
smoking status and serum cotinine levels found that cut-off points used ranged from 8 ng/mL to 
100 ng/mL62. Along with race, gene expression and medications competing with binding 
substrates63, as well as gender64 may all play a role in cotinine metabolism, and therefore cause 
variations person to person. Additionally, although cotinine has a longer half-life than nicotine, it 
remains in the system for only 15-20 hours65, which still may not capture the chronic, dependent 
smokers who seem to be most at risk for olfactory alteration. The cotinine measure is invasive 
and expensive, and, according to this analysis, appears less predictive of risk for olfactory 
alteration than the self-reported cigarette smoking behaviors.  
 The combination of smoking and heavy drinking showed a synergistic effect.  Being a 
dependent smoker and not a heavy drinker, or vice versa, was not a significant risk factor for 
altered olfaction in the adjusted logistic regression model, but the joint effect of the two 
associated with the highest risk. Although smokers tend to be heavy drinkers37, their joint effect 
has not been examined previously as a risk factor for olfactory alteration. Instead, studies use 
smoking as a covariate when examining the association with alcohol use40,41.  The present 
findings that the association between smoking and olfactory alteration depends on the 
smoking/heavy drinking relationship, chronicity of smoking, and/or dependency may partly 
explain the inconsistent reports in the literature.   
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The findings of the present study suggest that chronic dependent smoking alone, or in 
combination with heavy drinking, may increase risk of olfactory alteration through pathologies 
associated with olfactory dysfunction. That is, 22 and 34% of the association between smoking 
alone or with heavy drinking was explained by an olfactory risk score comprised of five 
pathologies (frequent nasal congestion, persistent cold/flu, presence of xerostomia, 
tonsillectomy, or history of a serious head/face injury). The direct effect of chronic dependent 
smoking as well as smoking and heavy drinking on olfactory alterations was also significant, 
indicating these behaviors also likely have a direct effect on olfactory alteration. Although the 
relationship between smoking, olfactory alterations, and these other olfactory pathologies have 
been examined independently, no study to our knowledge has examined this complex 
relationship simultaneously. Mediation modeling allows for testing of all variables and their 
relationships together, displaying the complex associations between all. This provides additional 
information that logistic regressions cannot, as regressions look at relationships separately, not as 
a whole66.  
Although this study utilized a nationally-representative sample of U.S adults, there are 
still limitations to acknowledge, including the cross-sectional design. The present study 
examined a variety of risk factors for olfactory alteration, however a few other risk factors were 
not considered such as physical activity levels and BMI. Additionally, measures of smoking that 
included cotinine levels were limited in sample size as they were only available in the NHANES 
2011-2012 wave and only self-reported olfactory alteration was examined. However, smoking 
status was measured using multiple indicators of heavy use and dependence through self-
reported and measured data. Future research should utilize the shown appropriate measures of 
smoking to accurately capture who is at risk for olfactory alteration, including the combination 
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of pack years and time to first cigarette in current smokers and pack years in former smokers. In 
addition, the relationship between smoking and olfactory function can be examined utilizing the 
new measured protocol in NHANES 2013-20141. Finally, other complex mediation relationships 
and combined lifestyle factors (e.g., heavy drinking) should be examined to fully understand the 
relationship of cigarette smoking on olfactory function.  
 
2.6 Conclusion 
In conclusion, this nationally-representative study found significant evidence that chronic 
dependent cigarette smoking alone or with heavy alcohol consumption was associated with 
increased odds of olfactory alteration, a composite index capturing self-reported problems during 
the past year, losses noticed with age, and phantom olfactory sensation.  Some of the risk of 
olfactory alteration in smokers or smokers/heavy drinking was direct and some was explained by 
an increased frequency of pathologies associated with olfactory dysfunction (frequent nasal 
congestion, persistent cold/flu, presence of xerostomia, tonsillectomy, or history of a serious 
head/face injury). The smoking effects on risk of altered olfaction were uncovered by 
characterizing smoking by chronicity as well as level of dependence.  
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CHAPTER THREE 
 
Heightened olfactory dysfunction and oral irritation among chronic smokers and 
heightened propylthiouracil (PROP) bitterness among menthol smokers 
 
3.1 Abstract 
 Chronic cigarette smoking can influence chemosensory function, which in turn affects the 
palatability of tobacco products and cessation efforts. We examined chemosensory function of 
chronic smokers in comparison to a national sample for olfaction (National Health and Nutrition 
Examination Survey, NHANES) and to a sample of non-smokers for taste. Chemosensation also 
was evaluated as a function of menthol versus non-menthol cigarette use.  We expected that 
chronic smokers would display altered chemosensory function that would vary by menthol use. 
Methods: Chronic smokers (N=78; 49 menthol smokers) self-reported their chemosensory 
function (per NHANES protocol) and participated in measures of smell (16-item olfactometer 
identification task) and taste (quinine and NaCl intensities, NHANES protocol) function, 
including a taste genetic probe (bitterness of propylthiouracil, PROP). Self-reported and 
measured olfactory function was compared with 2011-2012 NHANES data, and taste function 
was compared with age- and sex-matched non-smokers (n=311). Results: Olfactory alterations 
were reported by 25% of smokers, similar to NHANES prevalence. However, measured 
dysfunction (22% mild, 35% moderate, 3.8% severe microsmia and 1% anosmia) exceeded that 
reported in NHANES, but did not differ by menthol cigarette use. Taste alteration, including 
altered flavor, was reported by 15% of smokers. In comparison with non-smokers, smokers 
reported elevated intensities from NaCl at oral-irritant concentrations. Consistent with previous 
TAS2R38 taste receptor gene findings, menthol smokers reported greater bitterness from PROP 
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than non-menthol smokers.  These findings have implications for regulation of flavorings in 
tobacco. As with menthol cigarette preference among smokers with genetic propensity for 
elevated bitter perception, other flavors may also help drive smoking in chronic smokers with 
altered chemosensory function. 
 
3.2 Introduction 
 Although smoking prevalence has been declining over the past years, in 2014 over 40 
million adults (16.8%) in the United States were current smokers1. Of all cigarettes sold in 2012, 
31% were a mentholated brand2  and used more frequently by younger individuals and minority 
groups, specifically African Americans3. Makers of tobacco-based products commonly use 
flavor additives to mask bitterness, irritation and other unpleasant sensations from tobacco and to 
produce a smooth, mellow tobacco flavor. In particular, menthol has been used to produce a 
smoother, cooler smoke. Genetic variation in sensitivity to flavors and taste may influence 
smoking choices and behaviors. Thus, we sought in the present paper to investigate olfactory and 
taste function among adults who are current chronic smokers, and compare chemosensory 
function between menthol vs. non-menthol smokers.   
 In population-based samples, the rates of olfactory dysfunction range from 3.8%4,5  in the 
Beaver Dam Offspring Study, to 12.4% for the National Health and Nutrition Examination 
Survey (NHANES)6, and l9.1% for the Skövde population-based study7. These rates vary with 
demographic factors, with increased rates in older adults6,8,9, males9-14, certain ethnic/racial 
minorities6,9 and those with lower income/educational attainment5,6.  Common causes of 
olfactory alterations include frequent nasal infections, allergies15, injury to the head or face16 
[16], and viral infections/tonsillectomy6. Studies show that individuals are able to self-report 
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having a normal sense of smell (i.e., specificity) but are poor at self-detecting olfactory 
dysfunction (i.e., sensitivity)17,18.  However, through asking a series of questions about recent 
smell function, loss of sense of smell with aging, and phantom sensations (i.e., phantosmia), we 
have been able to achieve reasonable sensitivity in tests of self-identified olfactory dysfunction19.  
Research on the association between smoking and risk of olfactory dysfunction has been 
inconsistent. Several studies report no association between olfactory function and smoking when 
examining both measured and self-reported function in current compared to former or never-
smokers7,19-21.  Other studies show an elevated risk of olfactory dysfunction among current 
smokers8  and/or heavy smokers8,22. Recent analysis of the NHANES 2012 data, on the other 
hand, suggested decreased risk of olfactory dysfunction among current and past smokers, yet 
found an elevated risk of olfactory dysfunction among heavy drinkers6.  
Compared with olfactory dysfunction, taste dysfunction is less common23, due to the 
redundancy of the three taste-related nerves that carry the sensory information from the 
periphery to the central nervous system.  More common is regional taste dysfunction from an 
area of taste nerve innervations, which in turn alters whole mouth taste perception, touch/tactile 
and pain sensations24. More severe taste-related exposure could depress whole mouth taste 
function.  Major causes of taste dysfunction include xerostomia (persistent dry mouth), facial 
injuries, upper respiratory and middle ear infections, surgeries to the ear, nose or throat, and 
aging24.  Since individuals are usually unable to perceptually distinguish taste and retronasal 
olfactory sensations during ingestion, NHANES protocol queried on the ability to taste salt, 
sweet, sour and bitter, along with questions on changes in food flavor, and persistent tastes in the 
mouth (i.e., dysgeusia), which was combined into a taste alteration index19. The prevalence of 
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reported taste alteration (recent problems, loss in taste or flavor with age, dysgeusia) in adults 40 
years and older was 19%19.  
There are natural variations in the ability to taste, specifically, the ability to taste 
PTC/PROP bitterness relates to polymorphisms in the TAS2R38 receptor gene25,26. Given these 
taste variations, the question of interest was to determine if heightened ability to taste might be a 
sensory hindrance to smoking (or to smoking unflavored cigarettes), and if chronic smoking 
alters taste and oral sensations.  Although nicotine stimulates complex taste, olfactory and 
somatosensory sensations27, variation in bitter taste has been linked to differences in cigarette 
smoking behaviors. Nicotine stimulates bitter taste through TRPM5-dependent and independent 
mechanisms28.  Fischer29  in the 1960’s reported that smokers are less sensitive to bitter taste. In 
recent studies of bitter taste in humans, specifically bitterness of phenylthiocarbamide (PTC) and 
propylthiouracil (PROP), nontasters are more likely to be smokers30, show greater cigarette 
dependence31, and less nicotine aversion32. Additionally, PTC/PROP nontasters by TAS2R38 
genotype show more motivation to smoke based on sensory cues than do tasters33. It should be 
noted, however, that the TAS2R38 genotype-smoking effects are not always seen34, and the 
effects may be race/ethnicity specific35. Menthol in cigarettes may help smokers block the 
negative oral sensations from cigarettes36,37.  Females who are PTC/PROP tasters by TAS238 
receptor genotype are more likely to smoke menthol cigarettes38.   
Smoking itself may impair bitter taste perception or alter oral sensations, and smoking 
cessation may lead to improvements in bitter taste ability32.  Additionally, taste perception plays 
a key role in flavor preference39 and differences among smokers may influence flavor choice 
among nicotine products, such as mentholated cigarettes or electronic cigarettes. Long-term 
exposure to nicotine in rats decreased fungiform papillae size and changed their anatomical 
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characteristics40, which could explain lower density of tongue-tip taste papillae (fungiform 
papillae) among chronic smokers41.  Most studies report altered oral sensations among smokers, 
however the type of alteration varies. Studies have found elevated taste42 and touch43 sensations, 
elevated taste44 or taste/touch thresholds45, and greater risk of oral pain46 among smokers.  One 
study found no smoker effects on taste threshold47.   
Due to the complexity of smoking’s potential effects on chemosensory functioning, the 
aim of this study was to compare olfactory and taste function in chronic smokers with the 
olfactory functioning of a national sample from the National Health and Nutrition Examination 
Survey and the taste functioning of age- and sex-matched non-smokers. Additionally, we were 
particularly interested in the olfactory and taste function of menthol and non-menthol smokers. 
Finally, because this was a baseline examination of an electronic cigarette study, we aimed to 
identify if the flavor electronic cigarette smokers identified as their most preferred associated 
with their chemosensory functioning, or menthol status. It was hypothesized that chronic 
smokers would display altered chemosensory function, which would vary by menthol use and 
that electronic cigarette flavor preference would vary by menthol status or PROP taster profile. 
 
3.3 Methods 
3.3.1 Study Design and Participants 
The analysis sample of 79 adults (42 males) was obtained from the baseline data of a 
study on the effects of nicotine and flavorings on use of electronic cigarettes in regular smokers. 
Recruited into this study were adults in the greater Hartford, CT area, ages 18 to 55 years, who 
responded to newspaper and radio advertisements between May 2015 and March 2016.  A 
telephone screening protocol determined if the potential participants met the exclusion and 
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inclusion criteria for initial eligibility.  The criteria for exclusion were: 1) unstable medical or 
psychiatric disorders, including uncontrolled hypertension (BP>160/100); 2) pregnancy; 3) 
known hypersensitivity to nicotine or to propylene glycol; 4) previous M.I. or stroke; 5) insulin 
dependent diabetes; 7) and known COPD or asthma.  The criteria for inclusion included 1) 
current use of at least 10 cigarettes daily; 2) willing to abstain from cigarette smoking, and to 
substitute e-cigarettes, for approximately 6 weeks; 3) not currently planning to stop smoking 
(score <-2 on an Intentions to Quit scale48); and 4) able to read and sign a consent form in 
English. The study was approved by the institutional review board at the University of 
Connecticut Health Center. Participants provided informed and written consent and were paid 
$20 for participation in the baseline assessments. 
 
3.3.2 Procedure and Measures 
  Adults who met the inclusion/exclusion criteria were invited to participate in the baseline 
measurements.  During the initial screening process, participants completed the Smoking History 
Questionnaire [SHQ]49, a self-report questionnaire used to assess smoking history and pattern. 
The SHQ includes items pertaining to smoking products, brands used and smoking rate. 
Responses to brand used, specifically if a menthol brand is used, classified participants as non-
menthol or menthol smokers. Pack years were calculated based on smokers reported average 
cigarettes smoked/day since being a regular smoker, converted to packs a day, and multiplied by 
reported years smoking. Smokers were also classified by time to first cigarette (TTFC) upon 
waking (within 30 minutes or >30 minutes). TTFC is a marker for nicotine dependence50. During 
baseline procedures, participants also sampled five electronic cigarette flavors, by puffing on 
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them for one minute each, and rated their most preferred flavor (no flavor, tobacco, menthol, 
cherry, and chocolate).  
The chemosensory protocol took approximately 20 to 25 minutes during a 2-hour visit to 
the UCHC Clinical Research Center.  Participants first self-reported their olfactory and taste 
functioning using the NHANES protocol19,51, including problems within the past year, losses 
since age 25 years, and phantom sensations (dysgeusia, phantosmia/parosmia). Self-reported 
smell or taste alteration was an affirmative/negative response to having a problem within the past 
year, worse abilities since age 25, or a phantom sensation.  
All sensory intensity ratings were made on the general Labeled Magnitude Scale (gLMS), 
which generalizes the LMS52 to all sensations53.  The gLMS scale ranges from 0=nothing to 
100=strongest sensation of any kind, and intermediate labels of 6=barely detectable, 
17=moderate, 35=strong, and 53=very strong.  Participants were trained on using the generalized 
labeled magnitude scale (gLMS) following the procedures outlined in the NHANES but 
practicing the ratings with remembered sensations54 instead of LED-generated brightness 
sensations used for intensity ratings6. Previous research has shown that the gLMS generates 
intensity ratings consistent with magnitude matching53.  
Olfactory function was measured using a 16-item odor identification task and intensity 
ratings for each odor on the gLMS54.  The participants were instructed to identify the correct 
odor generated by an olfactometer (Osmic Enterprises, Inc., Cincinnati, OH) from four choices. 
Stimuli included food (cherry, strawberry, lemon, onion, coffee, cinnamon, chocolate, grape, 
vanilla), warning (gasoline, smoke, menthol) and household (soap, leather, baby powder, rose) 
odors. Participants who identified fewer than thirteen odors correctly were classified as having 
- 50 - 
 
an olfactory dysfunction (0-7 anosmia/severe hyposmia, 8-12 hyposmia). Those correctly 
identifying thirteen to sixteen odors were classified as normosmia.  
Taste functioning was measured with the NHANES protocol6,54.  Participants used the 
gLMS to report the intensity of concentrated 1mM quinine hydrochloride (QHCl) as well as 1M 
and .32 M sodium chloride (NaCl) drawn across the tongue tip and then sampled with the whole 
mouth54.  As a probe of genetic variation in taste26,55, participants also reported the intensity of 1 
and 3.2 mM PROP sampled with the whole mouth.  For analysis, participants were classified as 
nontasters if they reported the average intensity of PROP less than moderate on the gLMS, 
medium tasters between moderate and very strong, and supertasters greater than very strong. 
Retronasal function was measured using a jelly bean plug/unplug taste test. Four jelly 
bean flavors, cherry, coffee, chocolate, and Tabasco were used. Participants first rated the 
sweetness/flavor intensity of the jelly bean with their nose plugged using the gLMS. Then 
participants unplugged their nose and again rate the sweetness, flavor intensity, and their liking 
or disliking of the flavor. For the Tabasco jelly beans, participants also rated the intensity of the 
burn or irritation feeling while unplugged. The difference in flavor intensity rating from plugged 
to unplugged were calculated to examine retronasal function.  
 
3.3.3 Data Analysis 
Statistical analyses were conducted using SPSS version 22 (Chicago, IL) with 
significance criterion of p≤.05. Descriptive analysis was used to compare self-rated and 
measured olfactory/taste functioning between smokers and the NHANES 20126,19 overall and by 
age decade.  
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Smokers were matched to a non-smoker sample (n=311) from our laboratory database 
using propensity score matching with the MatchIt56 R package (www.r-project.org).  The 
propensity score was estimated by logistic regressions matching for age and sex initially and then 
for age, sex and PROP tasting to test for differences in quinine and NaCl intensity (which vary 
with PROP bitterness53,57) using the method of nearest to match non-smokers to smokers with the 
closest propensity score. A 3:1 control to case ratio was used, which is preferred over 1:1 
matching for increased statistical power and decreased standard errors58,59.  Differences in taste 
function between smokers and non-smokers or within menthol and non-menthol were first 
assessed with group and sex analysis of covariance, controlling for age effects, and then assessed 
for differences in distribution with either chi-square or Kolmogorov-Smirnov test. 
Retronasal jelly bean tests and preferred electronic cigarette ratings were examined for 
correlations and associations with olfactory and/or taste dysfunction as well as differences by 
menthol status or PROP taster classification. 
 
3.4 Results 
Table One describes the socio-demographic, lifestyle behaviors, and health conditions of 
the study participants by menthol smoker status. Average age of the entire sample was 35 ± 10 
years. The average years smoked of the sample was 18.2 ±11 years, with an average of 11.5 ± 
9.3 pack years. Eighty-one percent of the sample reported smoking within 30 minutes of waking 
in the morning.  
Significantly more menthol smokers were single/divorced than non-menthol smokers (x2= 
7.36, p<.01), having less than $40,000 household income (x2= 10.9, p<.01) than non-menthol 
users, and significantly more were Black (x2=4.24, p=0.04) compared to non-menthol users. In 
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comparison with a general population sample of adults in Connecticut from the Behavioral Risk 
Factor Surveillance System for Connecticut in 201360, fewer smokers in the current study were 
of normal weight (23.1 vs 35.6%, respectively), and more were obese (39.7 vs. 25%, 
respectively).  
 
Table One: Demographic and health characteristics of chronic smokers by menthol 
smoking status  
Characteristics Non-Menthol  
(32) 
Menthol  
(47) 
Gender   
     Male 56.3% 51.1% 
     Female 43.8% 48.9% 
Age (years) (mean ± SD) 35.5 ± 9.6 34.8 ± 10.5 
Marital Status   
       Single 46.9% 76.6% 
       Married 53.1% 23.4% 
Race   
    Black 6.3% 23.9% 
    White 93.8% 71.7% 
    MultiRace 0% 4.3% 
Household Income >$40,000 71.9% 34.0% 
Education Level (%)   
    < High school  6.3% 6.5% 
    ≥ High school  93.8% 93.5% 
Average Years Smoked (mean± SD) 19 ± 9.6 17 ± 12 
Average Cigarettes smoked/day (mean ± SD) 12.9 ± 6.6 12 ± 6.5 
Average BMI  28.5  29.9 
         Underweight (<18.5) 0% 2.1% 
         Normal (18.5-24.9) 31.3% 23.4% 
         Overweight (25-29.9) 37.5% 34.0% 
         Obese Grade I (30-34.9) 15.6% 21.3% 
         Obese Grade II (35-39.9) 6.3% 10.6% 
        Obese Grade III (≥40) 9.4% 8.5% 
Tonsils Removed 18.8% 14.9% 
Persistent Cold/flu 3.1% 8.5% 
Persistent Dry Mouth 12.5% 10.6% 
Frequent nasal congestion/allergies 25.0% 29.8% 
Suffered from a serious head injury 31.3%  25.5% 
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3.4.1 Self-reported olfactory and taste alteration 
As shown in Table Two, the percent of chronic smokers reporting alteration in olfaction, 
taste or both was very similar to that found in the NHANES 2011-201219.  However, there was 
less overlapping of the responses in forming the alteration indexes, as fewer chronic smokers 
reported phantom smell or taste sensations. 
Table Two: Rates of self-reported olfactory and taste alteration compared with the 
NHANES 2011-1219 and olfactory dysfunction compared with the measured prevalence in 
the NHANES 20126 
Self-reported Alteration† 
% of Prevalence in 
Smoker Sample (n=79) 
NHANES 2011-2012 
(n=>3000) 
Olfactory Alteration 25.3 23.0 
Smell problem in last year 12.7 10.6 
Loss since age 25 14.1 16.7 
Phantom odors 1.3 6.0 
Taste Alteration 15.2 18.7 
Taste problem in last year 7.6 5.3 
Loss since age 25 (salt, sweet, sour, or 
bitter) 
1.5-5.1 3.6-4.7 
Loss of food flavor since age 25 6.4 10.0 
Dysgeusia 0.0 5.0 
Combined Olfactory and Taste Alteration 
11.4 10.0 
Measured Olfactory Dysfunction 
% of                                                     
Smoker Sample (n=78) 
Prevalence in                                
NHANES 2012 
(n=1281) 
Total 40.5 12.4 
Anosmia/Severe Hyposmia 1.4 3.2 
Hyposmia 39.2 9.2 
Normosmia 58.2 87.6 
† Sub-scores will not sum to total alteration index because of overlapping responses. 
3.4.2 Measured olfactory function 
The rate of olfactory dysfunction among this sample of chronic smokers was 40.5%, 
which was higher than the 12.4% overall NHANES prevalence (8-item scratch and sniff odor 
identification task)6, which included adults from the 4th to 8th decades of age (Table Two).  The 
- 54 - 
 
rate of hyposmia in chronic smokers (39.2%) also exceeded the rates in NHANES among those 
in the 4th (2.5%) and 5th (8.1%) decades of age6. The percentage of chronic smokers with 
olfactory dysfunction increased with age; 33% in those less than 40 years of age, 40% in those 
under 50 and 100% in those 50 to 55.  The number of odors correctly identified did not vary 
significantly among the female and male smokers. Rates of olfactory dysfunction among 
smokers did not vary by menthol status (35.5% non-menthol vs. 44.7% menthol) yet the menthol 
smokers tended to have greater variance in the distribution (F-test on variances=1.85, p=0.07). 
Rates of olfactory dysfunction among ≥10 pack year smokers (average 19.2 pack years) were 
48.6% compared to 35% in <10 pack year smokers (average 4.5 pack years). This was not a 
statistically significant difference (p=0.25) and did not vary by menthol status.  
Olfactometry indicated that prevalence of olfactory dysfunction among the chronic 
smokers was much higher than that suggested by self-report. Comparing the sensitivity and 
specificity of self-report against measured olfactory alteration, individuals had much better 
specificity (correct identification of normal), at >76.3%, than sensitivity (correct identification of 
dysfunction) at <50%. The best sensitivity and specificity was found in individuals who 
identified ≤10 smells correctly, indicating that individuals with more severe dysfunction are 
better at identifying when they have a problem than individuals with mild dysfunction.  
 Of the specific odors, onion (100% identified it correctly) and coffee (97.4% identified 
correctly) were the odors most frequently identified correctly. Chocolate (51.3% identified 
incorrectly) and gasoline (51.3% identified incorrectly) were the odors most frequently identified 
incorrectly. Of the overall sample, 24.4% did not correctly identify menthol, with more menthol 
smokers not identifying the odor correctly compared to non-menthol smokers (27.7% vs. 19.4% 
misidentified respectively); this difference did not reach statistical significance.  The intensity of 
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the odors ranged from ≤moderate (chocolate, menthol), moderate to strong (strawberry, gasoline, 
smoke, lemon, cinnamon, rose, vanilla, cherry, leather, baby powder), to ≥strong (soap, grape, 
coffee, onion).  In odors repeated in our previous study, compared with age- and sex matched 
non-smokers54, these chronic smokers reported significantly lower intensities for smoke, coffee, 
menthol and onion but not for chocolate. 
 
3.4.3 Measured taste function 
 Relative to non-smokers, the smokers tended to have higher PROP ratings when controlling 
for age and sex effects.  In chi-square analysis, the chronic smokers had a higher frequency of 
supertasters than did non-smokers (nontasters 18.62 vs. 22.1%; medium tasters 56.3 vs. 36.4%; 
super tasters 25.1 vs. 41.6%, respectively; x2=10.2, p<0.01).  Because of these PROP effects, the 
non-smokers were matched on age, sex and PROP bitterness to test for quinine and NaCl 
intensity differences between smokers and non-smokers. 
 The smokers reported quinine intensity on the tongue tip as between moderate and strong 
and significantly less than NaCl intensity on the tongue tip, which averaged between strong and 
very strong (28.19±2.41 vs. 41.03±2.58, respectively; t=6.24, p<.001).  The distribution of these 
tastants on the tongue tip were significantly skewed to higher intensity compared with age-, sex- 
and PROP- matched controls (Figure One).  For the whole mouth, the smokers reported quinine 
and 1 M NaCl just above very strong and the .32 M NaCl between strong and very strong.  In 
comparison with the age-, sex- and PROP-matched nonsmokers, the smokers were not varied in 
the distribution of intensity from whole mouth quinine and .32 M NaCl, but were significantly 
skewed to higher intensity from 1 M NaCl (Figure One).  
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Figure One: The distribution of taste intensity among chronic smokers (hatched bars) and 
non-smokers (solid grey bars) following the NHANES taste testing protocol [53] with the 
gLMS categories [52] on the x-axis and percent of smoker/non-smoker group on the y-axis 
tested by the chi-square statistics 
 
3.4.4 Taste function between menthol and non-menthol smokers 
 In analysis of covariance, the menthol and non-menthol smokers did not vary significantly 
in average or distribution in intensity of tongue tip quinine or NaCl and whole mouth NaCl (1M, 
.32 M) or quinine.  However, the distribution of the average bitterness of 1mM and 3.2 mM 
PROP was significantly different in menthol smokers than among non-menthol smokers 
(D=0.31, p<0.05).  Figure Two shows the distribution of nontasters (PROP<moderate), medium 
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tasters (PROP between moderate and less than very strong), and supertasters (PROP≥ very 
strong).  There tended to be significantly fewer PROP nontasters but more supertasters among 
the menthol smokers than non-menthol smokers (x2=5.21, p=0.074).  
Figure Two: The distribution of propythiouracil taster status among chronic smokers who 
smoke menthol (black bars) and non-menthol (shaded bars) cigarettes with the gLMS 
categories53 on the x-axis and percent of smoker/non-smoker group on the y-axis tested by 
the chi-square statistic. 
 
 
3.4.5 Retronasal function 
Overall, the flavor intensities heightened as participants rate plugged and then unplugged 
jelly bean flavor intensities, with the biggest increase in sweetness intensity seen with the coffee 
jelly bean flavor (mean +19.3) (Table Three). The flavor intensity ratings (unplugged) ranged 
from between moderate and strong (chocolate mean 24.5) to close to strong/very strong (Coffee 
mean 40.8). Cherry was the most liked jelly bean (mean liking of +35), and Tabasco was the 
only mean disliked jelly bean (mean disliking of -26.63). The Tabasco jelly bean’s irritation 
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intensity was rated as a mean of 31.64. There was no significant difference in any ratings by 
menthol status.  
 Measured olfactory dysfunction (<13 correctly identified odors) was not associated with 
depressed change in flavor intensity rating from plugged to unplugged, and was not associated 
with depressed jelly bean flavor intensity ratings. There was no correlation between number of 
smells identified correctly by olfactometry and either difference in flavor intensity rating plugged 
to unplugged or flavor intensity rating alone (unplugged). However, those individuals with worse 
dysfunction (<10 correctly identified odors) had significantly lower Tabasco flavor intensity 
ratings than those without severe dysfunction (27.5 vs. 51.6 p=0.04) but no other jelly bean 
flavors varied. This suggests that retronasal olfaction may not be affected by smoking as 
orthonasal olfaction may be.  
 When examining jelly bean ratings by taster group (nontasters= <17, medium tasters 17-
53, supertasters >54 PROP intensity ratings), there was a trend in increasing flavor intensity 
ratings for all jelly bean flavors between nontasters and supertasters, but this did not reach 
significance.  
Table Three: Change in jelly bean flavor intensity rating from unplugged rating to plugged 
rating 
 
 
3.4.6 Preferred electronic cigarette flavor 
The most preferred electronic cigarette flavor was cherry (31.4%), followed by menthol 
(30.4%) and tobacco (26.6%). Preferred electronic cigarette flavor did not significantly differ by 
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sex, however did differ significantly by BMI class using fishers exact test. Those who were 
obese most frequently rated cherry flavor as their most preferred flavor compared to normal 
weight individuals (p= <0.005).  
 There was no association between measured olfactory dysfunction and preferred electronic 
cigarette flavor. However, smokers who were supertasters based on PROP intensity classification 
most frequently reported menthol electronic cigarette as their most preferred flavor, compared to 
nontasters (40.6% vs. 23.5% respectively), although this did not reach statistical significance.  
Favorite electronic cigarette flavor also differed significantly by menthol status. Menthol 
smokers rated menthol the favorite flavor more frequently than non-menthol smokers (46.8% vs. 
6.3%, p=<0.001) and non-menthol smokers rated tobacco the favorite flavor more frequently 
(59.4% vs. 4.3%, p=<0.001). 
 
3.5 Discussion 
This study involved chemosensory phenotyping of a sample of chronic smokers. In 
standardized chemosensory testing these chronic smokers showed 3 to 4-fold higher frequency of 
measured olfactory dysfunction than that observed in the nationally-representative sample from 
the NHANES6.  Despite this high prevalence, the smokers were unaware of the dysfunction 
unless it was at the level of severe hyposmia/anosmia as we have seen previously6,61.  Retronasal 
function did not seem to be altered by cigarette smoking as orthonasal olfaction was found to be. 
The chronic smokers also reported heightened taste intensities from NaCl in comparison to non-
smoker controls, occurring not at concentrations where salt is primarily a taste (0.32 M), but at 
levels of salt as an oral irritant (1 M)62 on the tongue tip as well as with whole mouth perception.  
We did not find that smokers were more likely to be nontasters of PROP (a phenotypic marker of 
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genetic variation in taste) in comparison to controls.  However, among the chronic smokers, 
those who reported smoking menthol cigarettes were more likely to report elevated bitterness 
from PROP. Electronic cigarette flavor preference did vary by menthol-status, with more 
menthol smokers preferring menthol flavor and more non-menthol smokers preferring tobacco 
flavor, and by BMI class, however there were no statistically significant differences between 
preferred electronic cigarette flavor and olfactory function or taster groups.  
Chronic exposure to smoking may cause direct damage to the peripheral nerve system to 
explain our findings of elevated olfactory dysfunction among smokers.  In animal models, 
chronic exposure to smoking as well as ethanol is associated with olfactory epithelial neuron 
death, undermining the regeneration capacity to maintain functional tissues63.  Our rates of 
olfactory dysfunction exceeded that in the NHANES study, which also utilized an odor 
identification task but with a scratch and sniff procedure6,54.  Odor identification requires the 
ability to detect and correctly label an odor, which requires olfactory and cognitive processes10.  
Loss of olfaction occurs with mild cognitive impairment10 and cognitive impairment has been 
noted among smokers64.  The present study utilized olfactometer generated-odors; the odor 
intensities reported by the smokers were generally less than those reported by age and sex-
matched non-smokers for most odors, including menthol54.  Smoking also could have an indirect 
relationship with olfactory dysfunction through other risk factors (e.g., head trauma, upper 
respiratory tract infection, sinonasal disease)65,66. It is interesting that we did not observe the 
usual sex difference in olfactory functioning with women exceeding men in functioning.  
Females may suffer greater negative effects of smoking on olfactory dysfunction than males5.   
Our data did not indicate that smokers have depressed taste perception, either in ability to 
taste regionally on the tongue tip or with whole mouth experiences.  Instead, relative to non-
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smokers, the smokers here had a greater response to 1 M NaCl, an oral chemical irritant62, which 
is consistent with the elevated oral irritation and pain seen in previous studies46,67.  Other 
components of somatosensation, however, do tend to be depressed in smokers including thermal 
sensitivity43.  The elevated intensity of NaCl irritation could not be explained by loss of taste as 
seen with history of middle ear infections or taste nerve damage24. The regional differences in 
taste and oral irritation could also reflect genetic variation68.   
We did not note any alteration in retronasal function, and it did not associate with 
orthonasal olfactory dysfunction via olfactometry. Studies have shown there are differences in 
the perception and processing of orthonasal stimuli versus retronasal stimuli69, which may 
account for these findings. One pathway may present as normal while the other can present with 
dysfunction. Retronasal olfaction also interacts with the gustatory system69, which we did not 
find to be depressed in smokers. In fact, because the taste functioning may be heightened in this 
smoker sample, this may have countered any alterations to retronasal functioning.   
Genetic variation in taste as indicated by the ability to taste the bitterness of PROP was 
not different in our chronic smokers versus controls, but did vary by menthol cigarette 
preference. We did not observe more PROP nontasters among our sample of chronic smokers, 
which is inconsistent with previous findings of higher prevalence of nontasters among 
smokers29,30.  In fact, we observed higher PROP tasting ability among these smokers by the 
intensity of PROP bitterness alone.  Our testing employed aqueous solutions of concentrated 
PROP, which is more intense than commercially available PTC strips.  Frequently, PROP tasting 
categories of nontaster, medium and supertaster are defined as the PROP to NaCl intensity ratio, 
with nontasters having the lowest ratios (<0.4) and supertasters the highest (>1.2)55,70.  However, 
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our findings with NaCl suggest that this ratio could falsely shift the PROP/NaCl ratio toward 
more nontasters and fewer supertasters.   
Consistent with findings that female tasters by TAS2R38 receptor genotype were more 
likely to smoke menthol cigarettes38, the present study found that, relative to non-menthol 
smokers, menthol smokers were skewed toward reporting that PROP had greater bitterness.  This 
finding did not generalize to the bitterness of quinine, just for PROP, which may indicate a 
stronger taste genetic component to this relationship. Menthol may improve the ability to tolerate 
the unpleasant sensations of nicotine by providing a minty odor71 and oral and nasal cooling72, 
especially for younger smokers and minorities73.  
In regards to preferred electronic cigarette by the smokers in the study, significantly more 
menthol smokers rated the menthol flavor as their most preferred than non menthol smokers. 
Similarly, more supertasters rated the menthol electronic cigarette flavor as their most preferred. 
This did not reach statistical significance, but may be due to the limited sample size. As previous 
research notes, supertasters are more likely to smoke menthol cigarettes38, and these current 
findings support this with other menthol flavored nicotine products as well. In addition, obese 
individuals most frequently reported the cherry flavor electronic cigarette as their most preferred. 
Research suggests obese individuals have a stronger attraction and preference to sweet than 
normal weight individuals74.   
This study had a number of limitations including a convenience sample of chronic 
smokers and reliance on self-reported history.  The taste protocol did not include all taste 
qualities.  Nonetheless, the sample was well characterized for smoking status and phenotyped 
with measures that could be compared with the new NHANES self-reported and measured 
olfactory functioning6,54.  The taste testing also followed the NHANES protocol for future 
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comparison to national norms, including aqueous tastants compared with matched controls.   
 
3.6 Conclusion 
In summary, this sample of chronic smokers showed elevated levels of olfactory 
dysfunction but no evidence of taste dysfunction.  Smokers had better sensitivity than specificity 
of this olfaction issue, and it did not differ by menthol status. The smokers reported heightened 
irritation from a concentrated NaCl solution compared to non-smokers.  Menthol smokers were 
more likely to be bitter tasters of PROP, the probe for genetic variation in taste. Similarly 
menthol smokers were more likely to choose menthol flavored electronic cigarettes than non-
menthol smokers, and favorite flavor also varied by BMI. These findings allow for both future 
insight into tobacco and nicotine product regulation and baseline data for interventions studies, 
particularly those that might employ flavored nicotine replacement modalities, such as electronic 
cigarettes.  
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CHAPTER FOUR 
 
CONCLUSION 
4.1 Important Findings 
 This research was conducted to further examine the chemosensory abilities of cigarette 
smokers. Utilizing a nationally-representative as well as a community-based sample, we were 
able to use sophisticated characterization of smoking, and both self-report and objective 
measures of chemosensory function. The research supported that chronic and dependent cigarette 
smokers display olfactory dysfunction/alteration more frequently than do non-smokers, but do 
not appear to display retronasal dysfunction or taste dysfunction. Instead, smokers reported 
greater oral irritation by concentrated sodium chloride solutions, and menthol smokers 
specifically reported heightened propylthiouracil (PROP) bitterness. In addition, electronic 
cigarette flavor preference varied by menthol status, PROP taster classification, and weight. 
These results add to the body of literature on chemosensory abilities of cigarette smokers, and 
help clarify potential reasons for the conflicting findings. In addition, these findings indicated 
another potential benefit for smoking cessation – improving chemosensory function – and 
suggested that smoking is a modifiable risk factor that can help prevent and decrease the 
prevalence of olfactory dysfunction. Finally, these results provided baseline characterization of 
chronic smokers, allowing for comparison of function with cessation or switching to electronic 
cigarettes, and can provide insight that can be used for nicotine production regulation. 
 Broader characterization of smoking status was crucial when examining who was most at 
risk for a chemosensory alteration. Both chapters two and three involved characterization of 
chronic and dependent smokers based on pack years and time to first cigarette of the day. In the 
NHANES sample, classification of smoking status by current/former/never did not result in 
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increased odds of an olfactory alteration in either current or former smokers compared to never 
smokers. Smoking status required further classification, identifying chronic and dependent 
smokers, defined as ≥10 pack year, <30 minute TTFC smokers, to be at increased risk of an 
olfactory alteration compared to never/former smokers. Former chronic smokers (≥10 pack year) 
also were at increased odds of self-reported olfactory alteration, compared to never smokers. 
However, in the e-Cigarette sample of current chronic smokers, self-reported olfactory function 
in smokers was not significantly different than the general population, despite having a greater 
frequency of olfactory dysfunction than the general population. The scientific literature has 
indicated that self-reported function has good sensitivity, but relatively poorer specificity, 
particularly in recognizing less severe olfactory dysfunction. The chronic smoker sample 
examined in chapter three most frequently showed measured hyposmia, which is less severe than 
anosmia. Therefore, this thesis points to the need to use more than one measure of chemosensory 
function, utilizing both self-report and objective measures when possible, to capture more 
individuals who may suffer from olfactory dysfunction or alteration.  
 In addition to the finding that cigarette smokers may be at risk for olfactory alteration, 
other health behaviors and issues associated with cigarette smoking influence the cigarette 
smoking-olfactory alteration relationship. The NHANES analysis displayed that smokers who 
were also heavy drinkers had the greatest odds of an olfactory alteration, even greater than being 
a smoker alone. In addition, a portion of the relationship between smoking alone and in addition 
to heavy drinking was explained through other olfactory-related pathologies, including sinonasal 
problems, xerostomia, head/face injury, and history of a tonsillectomy. These results highlight 
the importance of examining the complete relationship of risk factors and health behaviors to 
fully capture those at increased risk for olfactory alterations. Those individuals with multiple 
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addictions may be most at risk for chemosensory issues. Studies and clinical facilities must take 
the time to probe complete behavioral and medical histories.  
 Furthermore, the e-Cigarette study analysis neither revealed taste dysfunction among 
chronic smokers, nor showed that chronic smokers as more likely to be PROP nontasters as 
compared to non-smokers. Chronic smokers reported heightened irritation from a concentrated 
NaCl solution compared to non-smokers, not at the concentration of a tastant, but at the 
concentration of an oral irritant. This heightened irritation may potentially affect diet quality and 
quality of life, and these implications should be explored further. In addition, menthol-smokers 
reported elevated PROP bitterness intensity compared to non-menthol smokers, indicating 
genetic variations among this smoking sub-sample. These menthol/PROP supertasters, also 
preferred menthol electronic cigarette flavor more frequently than non-menthol/PROP non-taster 
smokers. This indicates that taste profiling may indicate those more likely to smoke menthol 
cigarettes or flavored electronic cigarettes and associated health implications. 
 These studies suggest that chronic smokers (10+ PY smokers), who are also nicotine 
dependent (<30 min TTFC), have differences in chemosensory function compared to non-
smokers, including increased frequency of olfactory dysfunction and heightened oral sensations. 
Smoking must be characterized thoroughly in order to see these differences, pointing to a 
potential reason why previous literature has found such conflicting results.  
 
4.2 Implications for Future Research 
 Findings from this research help fill a gap in the literature, as smoking’s association with 
chemosensory function has not been thoroughly examined utilizing sophisticated 
characterization of smoking, specifically focusing on chronic and dependent smokers. We found 
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that smokers do present with olfactory dysfunction and heighted oral irritation, which indicates 
another benefit to smoking cessation that can be made aware to the public. Additionally, results 
from these studies provide baseline data on the chemosensory abilities of cigarette smokers, 
which can be used in the future to examine changes in these functions with cessation or 
switching to electronic cigarettes. Future studies should also examine the impact these 
heightened taste functions have on smoker’s diet quality, quality of life, and tendencies to smoke 
other flavored nicotine products. Furthermore, because current treatment options for 
chemosensory dysfunction are limited, prevention against these dysfunctions can be addressed 
through modifiable risk factors. Both cessation or not beginning cigarette smoking and heavy 
drinking can reduce the prevalence of chemosensory alterations.  
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Supplemental Material 
 
Unadjusted and adjusted odds ratios and 95% confidence intervals of risk factors 
associated with self-reported smell alteration in U.S adults by smoking class 
 
Table One: Current and former chronic smokers  
 
Variables 
Self-reported smell alteration 
Unadjusted Adjusted 
OR 95% CI OR 95% CI 
Age 1.007 1.001–1.014 1.00 0.99-1.008 
Sex (reference “female”)  
     Male 
1.009 0.90–1.13 0.99 0.85-1.17 
Race/Ethnicity (reference “white”)  
    Mexican American 
0.90 0.73–1.1 
  
 Other Hispanic 0.93 0.75–1.15   
 Non-Hispanic Black 0.80 0.65–0.98 0.85 0.67-1.09 
     Non-Hispanic Asian 0.50 0.37-0.68 0.76 0.53-1.09 
 Other race  1.48 0.85–2.57 
  
Marital Status (reference ”Married”)  
    Not  Married 
1.2 1.07–1.35 1.02 0.87-1.20 
Education (reference ” ≥high school”)  
     Less than high school 
1.12 0.93–1.37 
  
IPR (reference “>1”) 
 IPR ≤ 1 
1.40 1.18–1.64 1.23 1.00-1.50 
Sinonasal problems (reference ”no”)  
     Yes 
2.21 1.86–2.63 1.75 1.38-2.22 
Xerostomia (reference ”no”)  
     Yes 
2.40 2.04–2.83 1.80 1.52-2.13 
Head/Face Injury (reference ”no”)  
     Yes 
1.56 1.28–1.88 1.30 1.04-1.63 
Tonsils Removed (reference “no”) 
     Yes 
1.36 1.12–1.66 1.29 1.05-1.60 
Multiple Ear Infections (reference “no”) 
  Yes 
1.52 1.22–1.90 1.17 0.91-1.50 
Self-rated Health (reference “excellent, very 
good, good”) 
  Fair or poor 
1.63 1.36–1.95 1.23 1.02-1.48 
Heavy Drinking (reference “no”)  
     Yes 
1.76 1.35–2.31 1.38 1.00-1.91 
Smoking Status (reference “never smoker”)     
     <10 PY Light Smokers 
     Chronic  Smokers 
1.16 
1.75 
0.86-1.56 
1.45-2.12 
0.97 
1.36 
0.71-1.34 
1.06-1.74 
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Table Two: Chronic smokers stratified by current and former smokers 
 
Variables 
Self-reported smell alteration 
Unadjusted Adjusted 
OR 95% CI OR 95% CI 
Age 1.007 1.001–1.014 1.00 0.99-1.007 
Sex (reference “female”)  
     Male 
1.009 0.90–1.13 0.99 0.84-1.17 
Race/Ethnicity (reference “white”)  
    Mexican American 
0.90 0.73–1.1 
  
 Other Hispanic 0.93 0.75–1.15 
  
 Non-Hispanic Black 0.80 0.65–0.98 0.85 0.67-1.09 
     Non-Hispanic Asian 0.50 0.37-0.68 0.76 0.53-1.09 
 Other race  1.48 0.85–2.57 
  
Marital Status (reference ”Married”)  
    Not  Married 
1.2 1.07–1.35 1.03 0.87-1.22 
Education (reference ” ≥high school”)  
     Less than high school 
1.12 0.93–1.37 
  
IPR (reference “>1”) 
 IPR ≤ 1 
1.40 1.18–1.64 1.23 1.02-1.50 
Sinonasal problems (reference ”no”)  
     Yes 
2.21 1.86–2.63 1.75 1.38-2.22 
Xerostomia (reference ”no”)  
     Yes 
2.40 2.04–2.83 1.80 1.52-2.13 
Head/Face Injury (reference ”no”)  
     Yes 
1.56 1.28–1.88 1.30 1.04-1.63 
Tonsils Removed (reference “no”) 
     Yes 
1.36 1.12–1.66 1.29 1.05-1.60 
Multiple Ear Infections (reference “no”) 
  Yes 
1.52 1.22–1.90 1.17 0.91-1.50 
Self-rated Health (reference “excellent, very 
good, good”) 
  Fair or poor 
1.63 1.36–1.95 1.23 1.02-1.48 
Heavy Drinking (reference “no”)  
     Yes 
1.76 1.35–2.31 1.38 1.00-1.91 
Smoking Status (reference “never smoker”)     
     <10 PY Light Smokers 
     Current Chronic Smokers 
     Former Chronic Smokers 
1.16 
1.75 
1.72 
0.86-1.56 
1.34-2.37 
1.39-2.12 
0.97 
1.29 
1.42 
0.71-1.33 
0.93-1.80 
1.09-1.84 
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Table Three: Current chronic high dependent smokers  
 
Variables 
Self-reported smell alteration 
Unadjusted Adjusted 
OR 95% CI OR 95% CI 
Age 1.007 1.001–1.014 1.002 0.99-1.01 
Sex (reference “female”)  
     Male 
1.009 0.90–1.13 1.01 0.85-1.19 
Race/Ethnicity (reference “white”)  
    Mexican American 
0.90 0.73–1.1 
  
 Other Hispanic 0.93 0.75–1.15 
  
 Non-Hispanic Black 0.80 0.65–0.98 0.86 0.67-1.09 
     Non-Hispanic Asian 0.50 0.37-0.68 0.78 0.55-1.09 
 Other race  1.48 0.85–2.57 
  
Marital Status (reference ”Married”)  
    Not  Married 
1.2 1.07–1.35 1.02 0.85-1.21 
Education (reference ” ≥high school”)  
     Less than high school 
1.12 0.93–1.37 
  
IPR (reference “>1”) 
 IPR ≤ 1 
1.40 1.18–1.64 1.22 1.00-1.50 
Sinonasal problems (reference ”no”)  
     Yes 
2.21 1.86–2.63 1.80 1.43-2.26 
Xerostomia (reference ”no”)  
     Yes 
2.40 2.04–2.83 1.75 1.45-2.11 
Head/Face Injury (reference ”no”)  
     Yes 
1.56 1.28–1.88 1.35 1.08-1.68 
Tonsils Removed (reference “no”) 
     Yes 
1.36 1.12–1.66 1.28 1.03-1.59 
Multiple Ear Infections (reference “no”) 
  Yes 
1.52 1.22–1.90 1.16 0.91-1.48 
Self-rated Health (reference “excellent, very 
good, good”) 
  Fair or poor 
1.63 1.36–1.95 1.24 1.03-1.51 
Heavy Drinking (reference “no”)  
     Yes 
1.76 1.35–2.31 1.44 1.03-2.00 
Smoking Status (reference “never/former 
smoker”)     
       Light  Smokers (<10 PY/>30 min TTFC) 1.08 0.84-1.38 0.90 0.66-1.20 
      Current Chronic High Dependent Smoker 1.82 1.38-2.41 1.41 1.01-1.99 
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Table Four: Chronic Active Smokers 
 
Variables 
Self-reported smell alteration 
Unadjusted Adjusted 
OR 95% CI OR 95% CI 
Age 1.007 1.001–1.014 1.005 0.99-1.02 
Sex (reference “female”)  
     Male 
1.009 0.90–1.13 0.97 0.74-1.27 
Race/Ethnicity (reference “white”)  
    Mexican American 
0.90 0.73–1.1 
  
 Other Hispanic 0.93 0.75–1.15   
 Non-Hispanic Black 0.80 0.65–0.98 0.90 0.63-1.27 
     Non-Hispanic Asian 0.50 0.37-0.68 0.84 0.57-1.24 
 Other race  1.48 0.85–2.57 
  
Marital Status (reference ”Married”)  
    Not  Married 
1.2 1.07–1.35 1.08 0.88-1.31 
Education (reference ” ≥high school ”)  
     Less than high school 
1.12 0.93–1.37 
  
IPR (reference “>1”) 
 IPR ≤ 1 
1.40 1.18–1.64 1.48 1.13-1.96 
Sinonasal problems (reference ”no”)  
     Yes 
2.21 1.86–2.63 1.82 1.33-2.49 
Xerostomia (reference ”no”)  
     Yes 
2.40 2.04–2.83 1.53 1.12-2.09 
Head/Face Injury (reference ”no”)  
     Yes 
1.56 1.28–1.88 1.40 0.92-2.14 
Tonsils Removed (reference “no”) 
     Yes 
1.36 1.12–1.66 1.30 0.93-1.82 
Multiple Ear Infections (reference “no”) 
  Yes 
1.52 1.22–1.90 1.13 0.78-1.64 
Self-rated Health (reference “excellent, very 
good, good”) 
  Fair or poor 
1.63 1.36–1.95 1.22 0.90-1.67 
Heavy Drinking (reference “no”)  
     Yes 
1.76 1.35–2.31 1.57 1.03-2.38 
Smoking Status (reference “never/former 
smoker”)     
     Light smokers(<10 cotinine/<10 PY) 0.97 0.68-1.37 0.73 0.46-1.17 
     Chronic Active Smokers 1.56 1.00-2.49 1.22 0.72-2.05 
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Table Five: High Dependent Active Smokers 
 
Variables 
Self-reported smell alteration 
Unadjusted Adjusted 
OR 95% CI OR 95% CI 
Age 1.007 1.001–1.014 1.004 0.99-1.02 
Sex (reference “female”)  
     Male 
1.009 0.90–1.13 0.98 0.71-1.35 
Race/Ethnicity (reference “white”)  
    Mexican American 
0.90 0.73–1.1 
  
 Other Hispanic 0.93 0.75–1.15 
  
 Non-Hispanic Black 0.80 0.65–0.98 0.98 0.69-1.38 
     Non-Hispanic Asian 0.50 0.37-0.68 0.85 0.58-1.25 
 Other race  1.48 0.85–2.57 
  
Marital Status (reference ”Married”)  
    Not  Married 
1.2 1.07–1.35 1.02 0.83-1.25 
Education (reference ” ≥high school”)  
     Less than high school 
1.12 0.93–1.37 
  
IPR (reference “>1”) 
 IPR ≤ 1 
1.40 1.18–1.64 1.47 1.10-1.98 
Sinonasal problems (reference ”no”)  
     Yes 
2.21 1.86–2.63 1.84 1.34-2.52 
Xerostomia (reference ”no”)  
     Yes 
2.40 2.04–2.83 1.44 1.06-1.96 
Head/Face Injury (reference ”no”)  
     Yes 
1.56 1.28–1.88 1.45 0.95-2.22 
Tonsils Removed (reference “no”) 
     Yes 
1.36 1.12–1.66 1.36 1.00-1.85 
Multiple Ear Infections (reference “no”) 
  Yes 
1.52 1.22–1.90 1.09 0.76-1.57 
Self-rated Health (reference “excellent, very 
good, good”) 
  Fair or poor 
1.63 1.36–1.95 1.27 0.92-1.75 
Heavy Drinking (reference “no”)  
     Yes 
1.76 1.35–2.31 1.44 0.94-2.19 
Smoking Status (reference “never/former 
smoker”)     
      Light smokers(<10 cotinine/>30 min    
      TTFC) 
1.00 0.68-1.48 0.76 0.51-1.15 
    High Dependent Active  Smokers 1.62 1.00-2.62 1.22 0.77-1.93 
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Table Six: High Dependent Smoker-Heavy Drinker 
 
Variables 
Self-reported smell alteration 
Unadjusted Adjusted 
OR 95% CI OR 95% CI 
Age 1.007 1.001–1.014 1.003 0.99–1.01 
Sex (reference “female”)  
     Male 
1.009 0.90–1.13 1.05 0.88–1.26 
Race/Ethnicity (reference “white”)  
    Mexican American 
0.90 0.73–1.1 
  
 Other Hispanic 0.93 0.75–1.15   
 Non-Hispanic Black 0.80 0.65–0.98 0.82 0.62-1.07 
     Non-Hispanic Asian 0.50 0.37-0.68 0.78 0.55-1.11 
 Other race  1.48 0.85–2.57 
  
Marital Status (reference ”Married”)  
    Not  Married 
1.2 1.07–1.35 1.02 0.85-1.22 
Education (reference ” ≥high school”)  
     Less than high school 
1.12 0.93–1.37 
  
IPR (reference “>1”) 
 IPR ≤ 1 
1.40 1.18–1.64 1.18 0.96-1.45 
Sinonasal problems (reference ”no”)  
     Yes 
2.21 1.86–2.63 1.81 1.42–2.30 
Xerostomia (reference ”no”)  
     Yes 
2.40 2.04–2.83 1.74 1.46–2.09 
Head/Face Injury (reference ”no”)  
     Yes 
1.56 1.28–1.88 1.38 1.09–1.76 
Tonsils Removed (reference “no”) 
     Yes 
1.36 1.12–1.66 1.31 1.07-1.60 
Multiple Ear Infections (reference “no”) 
  Yes 
1.52 1.22–1.90 1.09 0.85-1.40 
Self-rated Health (reference “excellent, very 
good, good”) 
  Fair or poor 
1.63 1.36–1.95 1.27 1.00-1.62 
Smokers and Drinkers (reference 
“never/former smoker, non-heavy drinker”)     
   Dependent smoker, non-drinker 1.45 1.06-1.99 1.30 0.92-1.83 
    Non-smoker, heavy drinker 1.75 1.21-2.53 1.45 0.93-2.26 
   Dependent Smoker-heavy drinker 2.34 1.55-3.54 1.96 1.20-3.19 
 
 
